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To my family 
“The heart has its reasons which reason knows not.” 
― Blaise Pascal 
POPULAR SCIENCE SUMMARY OF THE THESIS 
Congenital heart defect, a heart condition present at birth, is diagnosed in one in every 100 
newborn babies. Congenital heart defects can affect different parts of the heart, and the 
clinical symptoms seen in a patient depend on the type of the defect. Some specific complex 
heart malformations cause cyanosis, which appears as a bluish skin color due to low oxygen 
content of the blood. In these patients, the oxygen poor blood which should be directed to the 
lungs for reoxygenation passes to the “wrong” side of the heart through a hole between the 
heart chambers, and enters the blood circulation through the aorta. Additional malformations 
are often present, which further hamper the heart’s pumping function and the blood flow 
through the heart. The symptoms range from none to severe, and in the latter case a surgery 
or other procedures are needed soon after birth to ensure the baby’s survival. 
The cause of the heart malformation found at birth is often unknown. Some risk factors have 
been identified, including maternal consumption of certain medications and drugs, alcohol, 
tobacco and maternal obesity. Children of parents with heart defects are also at risk, and 
genetics has been proposed as the main cause of cardiac birth defects. The majority of 
congenital heart defects are not associated with other diseases, but they are sometimes seen in 
patients with Down syndrome or other genetic syndromes and rare diseases. 
The congenital heart defects that have a genetic cause often arise early in the embryonic and 
fetal development, when something goes wrong on the molecular and cellular level. In some 
cases, the heart defect can be detected during pregnancy. Soon after birth, corrective surgeries 
can be carried out in order to close holes between cardiac chambers and redirect the abnormal 
blood flow. Although surgeries have significantly increased the lifespan and quality of life of 
the patients, congenital heart defects remain a major cause of child death globally. Therefore, 
development of new treatment strategies is a major goal of heart research. In order to develop 
novel therapies and improve the existing ones, more needs to be known about the genetic 
factors and disease mechanisms taking place during the early heart development before the 
baby is born. This kind of knowledge is the first step toward personalized gene and cell 
therapies and earlier diagnostics. 
To access and study human embryos in the earliest steps of heart development, when many of 
the congenital defects arise, is currently one of the great challenges of cardiovascular 
research. Therefore, mouse embryos and other animals have been traditionally used instead to 
study the genetics, cells and tissues related to heart development and disease. In the past 
decades, researchers have identified specific groups of cells and cellular mechanisms that are 
likely involved in congenital heart defects. The early embryonic cells, which later build the 
heart, are called cardiac progenitors. In the research included in this doctoral thesis, we aimed 
to increase the understanding on human heart progenitors in early heart development and 
their various roles in congenital heart defects. 
To access and model early human heart development, which cannot be accessed in human 
embryos, we used a so-called in vitro differentiation system. In this approach, human 
embryonic stem cells are converted into cardiac muscle cells, or cardiomyocytes, in a 
laboratory setting. Interestingly, although lacking the 3D structure of the developing heart, 
the heart cells in a cell culture dish follow similar developmental patterns as their 
counterparts in the developing human embryo, and actually start beating around day ten of 
the experiment. Due to the technical advancements, the differentiation process from a stem 
cell to a cardiomyocyte can be studied at the level of individual cells. This is what we did in 
the first study presented in this thesis in order to fully understand the road from a stem cell to 
cardiomyocyte. Using computer algorithms, we could visualize this path, and found branch 
points of different cell fates diverging from the same starting cells. Our study revealed the 
similarities between human embryonic heart and the heart development in a dish, identified a 
cell type related to the development of the connective tissue of the heart, as well as the 
developmental path of heart progenitors. 
In the second study we wanted to study the genetic causes of a specific type of complex 
cyanotic congenital heart defect in patients with healthy parents. To this end, parents of small 
children carrying this kind of heart defect were recruited to the study, and the genetic material 
of both the parents and the child was extracted and decoded computationally. This allowed us 
to identify genetic mutations that arose in the early development or in the reproductive 
(sperm and egg) cells leading to the child but not the parents having a heart defect. In some 
cases, both parents were carriers of risk mutations, which in combination caused a heart 
defect in the child. Bringing these observations together, we identified groups of genes that 
were especially affected by damaging genetic mutations, and grouped the disease genes 
according to their cellular functions. I contributed to the study by using the information about 
disease-causing mutations discovered in patients to pinpoint groups of early heart cell that are 
mostly affected by them, and found that the precursors of the heart muscle are the cellular 
hotspot of a specific type of congenital heart disease. 
In the third study presented in this thesis, we used the same single-cell approach as in the first 
study, but here we identified a specific early heart cell type that can be found both in the 
human embryonic heart and in the in vitro heart development model system. This cell 
population is closely involved in building the complex structures of the heart, which connects 
the heart muscle to the great vessels, or in other words aorta and pulmonary arteries. As this 
structure is especially sensitive towards genetic mutations, our study identified a cell 
population with high relevance for modeling congenital heart defects. 
To conclude, improving treatments and diagnostics for patients with complex congenital 
heart defects requires deep understanding of the normal heart development and genetics 
causing these defects on molecular and cellular level. In this doctoral thesis work, me and my 
colleagues built a roadmap of early heart cell differentiation (paper I); decoded the genetic 
mutations causing complex congenital heart defects and studied how they affect heart cells in 
early heart development (paper II); and identified a new cell population in the developing 
human heart, which may be closely involved in the early onset of congenital heart defects 
(paper III). 
ABSTRACT 
Cardiac progenitors are the fundamental building blocks of the heart and play a central role in 
the pathogenesis of congenital heart defects. Recent single-cell RNA sequencing studies have 
revealed that the cell populations in both developing and mature heart are more diverse than 
previously recognized. In particular, there has been a great interest in characterizing the 
transcriptional signatures of human cardiac progenitor populations and building a roadmap of 
the early heart lineages.  
This thesis work is a part of an ongoing effort to map the early human heart progenitors, their 
developmental dynamics and their role in the pathogenesis of congenital heart defects at a 
single-cell resolution. 
In paper I, we present a single-cell characterization of in vitro cardiac differentiation of 
human embryonic stem cells to beating cardiomyocytes and other populations. We used 
single-cell RNA sequencing data integration to compare the in vitro-derived cardiac cells to 
human embryonic heart, studied the developmental dynamics of cardiac progenitors by 
building a differentiation roadmap, and investigated the effect of loss of ISL1 transcription 
factor on the differentiation process.  
In paper II, we mapped the genetic landscape of non-syndromic Tetralogy of Fallot, a form 
of complex congenital heart defect, in a cohort of 146 patient-parent trios. We intersected the 
identified disease-associated genes with single-cell RNA sequencing analysis of in vivo and 
in vitro human cardiac development generated by us and other laboratories. Interestingly, we 
could pinpoint cardiac progenitors as a cellular hotspot in cardiac disease pathogenesis.  
Paper III introduces a novel cardiac progenitor marked by LGR5, which exists both in the 
human embryonic heart in vivo and the human embryonic stem cell cardiac differentiation 
system in vitro. The LGR5+ cono-ventricular progenitor population originates from the 
ISL1+ progenitor pool and populates the cardiac outflow tract, a cardiac region often affected 
in congenital heart defects. 
Taken together, these studies support the importance of cardiac progenitors in the 
pathogenesis of cardiac abnormalities and explore their developmental dynamics at a single-
cell level. 
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From the first heart beat to the last one, the human heart contracts more than two billion times 
over a lifetime. To get an early start, the heart is the first organ in an embryo to develop and 
initiate its function (Gilbert 2010). Building a heart is a complex process that depends on the 
differentiation and assembly of a family of cardiac lineages constituting its muscle 
compartments, vasculature, connective tissues and conductive system. These lineages appear 
early in embryonic development, pass through a sequence of progenitor stages and finally 
form the cell types found in the fully developed heart. (Meilhac and Buckingham 2018) 
The cellular mechanisms steering heart progenitors through their development, including 
formation, proliferation, migration, differentiation, commitment and assembly, are regulated 
by specific signaling pathways, transcription factors and other mediators. Identification of the 
various cardiac progenitor populations and studying the molecular mechanisms regulating 
them is essential for understanding the developmental biology of the heart as well as the early 
pathogenesis of developmental cardiac malformations (Witman et al. 2020).  
Congenital heart defect (CHD) is diagnosed in about 1% of all newborns and is therefore a 
significant health concern (Van Der Linde et al. 2011). Tetralogy of Fallot is the most 
common type of cyanotic CHD, and is characterized by the misalignment of the cardiac 
outflow tract, a complex developmental structure which later connects the cardiac ventricles 
and the great vessels (Apitz et al. 2009). Origins of complex CHD including Tetralogy of 
Fallot are not completely understood, but large cohort studies indicate that the cause is often 
genetic (Lalani and Belmont 2014).  
A large body of research has been dedicated to understanding the disease mechanisms behind 
CHD phenotypes. These studies include genetic analysis of patients (Richter et al. 2020; Page 
et al. 2019; Jin et al. 2017; Lalani and Belmont 2014) and mechanistic studies on cells, tissues 
and animal models to pinpoint the connection between genetic mutations and altered cellular 
functions (Sharma 2020; Moon 2008). It is increasingly clear that results from animal models 
do not perfectly translate to human (Brawand et al. 2011; Lin et al. 2014; King and Wilson 
1975). Therefore, there has been a large interest in generating cardiac progenitors and mature 
cells from human pluripotent stem cells (hPSCs) to be able to work on a human-based model 
system and access the developmental stages of cardiogenesis which cannot be accessed in 
human embryos (Protze et al. 2019). The hPSC-derived cardiac cells follow closely the 
developmental patterns of their counterparts in human embryonic heart (Später et al. 2014; 
Mummery et al. 2012), and therefore the hPSC cardiac differentiation provides a valuable 
model system for studying both cardiogenesis and CHD. 
Single-cell transcriptomics is a state-of-the-art method for analysis of cells and tissues in 
health and disease together with other single-cell approaches. With single-cell RNA 
sequencing it is now possible to build a detailed and comprehensive roadmap of the cardiac 
lineages derived from hPSCs and human prenatal tissues (Paik et al. 2020).  
2 
Relying on single-cell RNA sequencing, we focused on building a connected roadmap of 
hPSC-based cardiac differentiation (paper I), mapping the genetic and cellular disease 
mechanisms of Tetralogy of Fallot by cross-referencing genomic sequencing and single-cell 
transcriptomics (paper II) and studying the cellular heterogeneity of hPSC-derived and 
human embryonic/fetal cardiac cells (paper III). 
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2 PROGENITORS AND EARLY HEART DEVELOPMENT 
2.1 ANALYSIS OF HUMAN CARDIAC PROGENITORS 
Human cardiac progenitors are the focus point of this thesis, yet they are difficult to access. A 
growing number of research groups are studying human pre-implantation embryos to answer 
some of the fundamental questions of the early human development (Xiang et al. 2020; West 
et al. 2019; Zhou et al. 2019; Stirparo et al. 2018; Boroviak et al. 2018; Petropoulos et al. 
2016; Blakeley et al. 2015; Niakan and Eggan 2013; Yan et al. 2013). Culturing human 
embryos beyond the second week of embryonic development is ethically troublesome (Reyes 
and Lanner 2017), and consequently, human gastrulation and the subsequent events remain 
rather inaccessible for researchers. This is problematic for the study of human cardiogenesis, 
as the human heart development starts about 18 days after fertilization when the cardiac 
crescent arises (Sylva et al. 2013). Even studying the developmental stages which can be 
accessed in human (from about 4.5 weeks post conception [WPC]) is a challenge, as the 
human embryonic and fetal tissues available for researchers are sparse. 
The discovery of hPSCs and understanding the fundamentals of the early heart development, 
discussed in the next sections, have allowed the derivation of human cardiac progenitors and 
cardiomyocytes using various differentiation protocols (Protze et al. 2019; Später et al. 2014; 
Mummery et al. 2012). This has greatly advanced our knowledge about the molecular 
mechanisms underlying the human-specific cardiac specification and disease development 
(Protze et al. 2019). Furthermore, the hPSC-based cardiac differentiation provides a platform 
for drug screening and development of cell-based therapies for cardiac regeneration (Protze et 
al. 2019; Parrotta et al. 2019; Ye et al. 2018; Sala et al. 2016; Drawnel et al. 2014) (Figure 1).  
Figure 1. Derivation of hESCs from human blastocysts and the applications of hESC-derived 
cardiac cells. Created with BioRender.com. 
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With an access to a range of developmental stages of human cardiac progenitors, it is now 
possible to build a differentiation roadmap of early human heart development using single-
cell RNA sequencing (Paik et al. 2020). In particular, single-cell RNA sequencing has proven 
useful for studying the emergence and segregation of cardiac progenitors and lineages, and 
the molecular mechanisms regulating these events (Protze et al. 2019). Moreover, in 
combination with CRISPR/Cas9-mediated gene editing, molecular mediators of human 
cardiac differentiation can be characterized and defined (Lian et al. 2014), which is 
particularly useful for understanding genetic mutations underlying CHD pathogenesis. 
2.2 FROM MESODERM TO CARDIAC PROGENITORS 
To be able to generate human cardiac progenitors and cardiac cell types from hPSCs, it is 
essential to understand how the cardiac lineages develop in an embryo (Protze et al. 2019). 
We know the anatomical timing of cardiogenesis in human embryos (Sylva et al. 2013), and 
animal models have helped filling in many of the missing details of cellular and molecular 
mechanisms taking place in vivo. Here, I will give an overview of the in vivo differentiation 
of cardiac cell populations and cardiac morphogenesis. The human developmental time points 
and cellular and molecular insights from animal studies run in parallel in this overview. 
Human heart development starts from gastrulation at the end of the second WPC. Many 
biology students have heard the phrase “It is not birth, marriage, or death, but gastrulation, 
which is truly the most important time in your life” by Lewis Wolpert. During gastrulation, 
migration of cells through the primitive streak results in reorganization of a bilaminar 
embryonic disc, which makes the embryo within the blastula into a trilaminar disc composed 
of three germ layers: mesoderm, endoderm and ectoderm. Like most of the tissues of the 
cardiovascular system the heart mostly derives from lateral plate mesoderm, although 
derivatives of all three germ layers contribute to heart morphogenesis. (Meilhac and 
Buckingham 2018; Gilbert 2010) During gastrulation and the following events, Nodal 
signaling induces the expression of posterior-specific genes in the epiblast, which promotes 
the formation of mesoderm (Brennan et al. 2001). Canonical wingless type (Wnt)/b-catenin 
pathway induces the formation of Brachuyry/T-expressing mesoderm, and subsequent 
inhibition of canonical Wnt/b-catenin pathway and induction of non-canonical Wnt pathway 
leads to Mesp1-expressing cardiac mesoderm specification (Gessert and Kuhl 2010). Studies 
mapping early cardiac precursors in mouse and chicken have located the cardiogenic 
progenitors in the anterior part of the primitive streak (Garcia-Martinez et al. 1993; Tam et al. 
1997; Kinder et al. 1999). Based on Mesp1-Cre-driven lineage tracing, approximately 70% of 
the heart is generated by the Mesp1-expressing mesoderm (Lescroart et al. 2014; Saga et al. 
1999), including ventricular, atrial and outflow tract myocardium, endocardium, pericardium 
and the cardiac conduction system (Lescroart et al. 2018; Meilhac and Buckingham 2018). 
Around third week of the human development, 17-19 DPCs, the first region showing cardiac 
specification and commitment, the cardiac crescent, forms as two symmetrical parts of the 
mesoderm adjacent to the underlying endoderm (Sylva et al. 2013). The differentiation of 
cardiomyocytes from the cardiac crescent progenitors depends on paracrine signaling from 
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the endoderm and ectoderm including bone morphogenetic protein (Bmp), sonic hedgehog 
(Shh), fibroblast growth factor (Fgf), Wnt and Notch families of growth factors (Witman et 
al. 2020; Harvey, 2002, Lough and Suki 2000; Zaffran and Frasch 2002). Furthermore, the 
foregut endoderm provides signals steering the direction of cardiac progenitor migration, and 
plays a major role in the formation and shape of the cardiac crescent (Schultheiss et al. 1995; 
Nascone and Mercola 1995; Lough and Sugi 2000). At the cardiac crescent stage, the 
progenitors express various levels of several cardiogenic transcription factor- (e.g. Isl1, Nkx2-
5, Mef2c and Gata4), surface markers- (e.g. Pdgfra and Flk1) and early sarcomeric protein-
coding genes (e.g. Myl4, Myl7 and Tnnt2) (Behrens et al. 2013; Somi et al. 2004). 
Folding of the embryo starts at the end of the third week, bringing the two lateral parts of the 
cardiac crescent together and forming the anterior part of the primitive heart tube (Sylva et al. 
2013). Due to the automaticity of the early cardiomyocytes, the human heart tube starts to 
beat around 21-23 DPC (Vincent and Buckingham 2010). The heart tube is flanked by 
primitive inlet and outlets, the precursors of the inflow tract and outflow tract, bringing blood 
in and out of the developing heart (Sylva et al. 2013). 
2.3 HEART FIELD PROGENITORS 
Clonal analyses based on a-cardiac actin expression in mouse embryos revealed that the heart 
is mostly derived from two waves of cardiac progenitors (Meilhac et al. 2004). Subsequent 
studies have shown that those two populations are spatiotemporally guided by chemotaxis 
and regulated by cardiac transcription factors (Xiong et al. 2019; Waardenberg et al. 2014). 
The two cardiac progenitor lineages, first one giving rise to the linear heart tube and the 
second one gradually migrating to the poles of the heart tube, are called first heart field (FHF) 
and second heart field (SHF), respectively (Moorman et al. 2007; Buckingham et al. 2005; 
Kelly et al. 2001; Mjaatvedt et al. 2001; Waldo et al. 2001). The primitive heart tube 
generates the left ventricle and contributes to other parts of the heart, whereas cells migrating 
to the heart tube from the SHF generate the major part of the atria, outflow tract and right 
ventricle (Zaffran et al. 2004; Cai et al. 2003). The two cardiac lineages segregate as early as 
at the onset of gastrulation or even earlier (Meilhac et al. 2004), and show different 
developmental dynamics; the FHF progenitors directly commit to the cardiomyocyte lineage, 
while the SHF progenitors undergo a sequence of gradual commitment and differentiation 
(Xiong et al. 2019). Yet, it is still not clear whether the FHF and SHF differ in their 
fundamental progenitor potential or whether the differences between them are only due to 
their location in the developing heart (Tyser et al. 2021). 
Many of the early cardiac lineage marker genes, such as Gata4 and Nkx2-5, are expressed in 
both heart fields (Meilhac and Buckingham 2018), and definitive markers for the FHF are 
somewhat lacking (Buckingham et al. 2005). More specific to the FHF derivatives, 
transcription factor Hand1 has been shown to be expressed and regulate the left side of the 
developing murine heart (Biben and Harvey 1997; McFadden et al. 2005). Similarly, Tbx5 
mutant mice display hypoplasia of the left ventricle and atria, indicating an important role in 
the FHF derivatives (Bruneau et al. 2001). However, neither Hand1 or Tbx5 can be 
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considered exclusively as FHF markers, as both of them are expressed by subsets of SHF-
derivatives (Barnes et al. 2010; Rana et al. 2014). 
In contrary to the FHF, the SHF progenitors can be distinguished by their expression of 
specific genes, such as Isl1, Fgf8, Fgf10 and Tbx1 (Theveniau-Ruissy et al. 2008; Kelly et al. 
2001; Buckingham et al. 2005; Dyer and Kirby 2009; Watanabe et al. 2010). At the 
progenitor stage, they compose a rapidly proliferating and migratory population which is 
added to the primitive heart tube, whereas the differentiated myocytes do not contribute to the 
heart growth by division to any significant extent (van den Berg et al. 2009; Kelly et al. 2001; 
Mjaatvedt et al. 2001; Waldo et al. 2001; Cai et al. 2003). These developmental phases 
coincide with the expression of Isl1 and Nkx2-5, respectively (Buijtendijk et al. 2020). In 
particular, Cre-mediated lineage tracing in mouse revealed, that the transcription factor ISL 
LIM Homeobox 1 transcription factor (ISL1) broadly marks the SHF progenitors (Cai et al. 
2003), although another study showed that some of the cardiac Isl1-derivatives are of neural 
crest origin (Engleka et al. 2012). Lineage tracing and clonal assays of mouse cardiac 
progenitors have further shown that the Isl1-expressing SHF-derivatives include myocardial 
as well as endothelial and smooth muscle cells (Moretti et al. 2006; Laugwitz et al. 2005). 
This is also true for ISL1-cardiac progenitors derived from hPSCs (Bu et al. 2009). The 
hPSC-derived ISL1+ cardiac progenitors are of specific interest for regenerative medicine 
applications, as they have been shown to generate ventricular-like progenitors, with potential 
to engraft, expand, differentiate, self-assemble and maturate upon transplantation into mouse 
heart and kidney (Foo et al. 2018).  
It should be noted that although the ISL1+ heart progenitors have been identified in human 
prenatal heart (Yang et al. 2013; Bu et al. 2009), it is not yet completely clear what the 
species differences are and if the human and mouse heart fields behave in a similar manner 
(Pandur et al. 2013). 
2.4 OTHER PROGENITORS AND LINEAGES 
The majority of the cells of the heart are cardiomyocytes (Zhou and Pu 2016). However, 
connective tissue cells, namely fibroblasts, smooth muscle cells and endothelial cells, 
comprise a significant portion of the volume of the heart and carry out various important 
functions (Zhou and Pu 2016; Banerjee et al. 2007). In addition to the heart field progenitors, 
other lineages are required to build these cell types, including the neural crest. Endocardium, 
pericardium and myocardium arise from the cardiogenic Mesp1-expressing mesoderm and 
share common markers, such as Isl1 and Nkx2-5 (Ma et al. 2008; Sun et al. 2006; Cai et al. 
2003; Saga et al. 2000; Saga et al. 1999; Mikawa et al. 1992; Kaufman and Navaratnam 
1981), while cardiac neural crest cells are derivatives of the neuroectoderm (Jiang et al. 
2000). 
Endocardial cells first generate the inner epithelial lining of the myocardial heart tube, and 
later the inner layer of the heart chambers (Sylva et al. 2013). Both myocardial and 
endocardial progenitors express Isl1 and Nkx2-5 (Ma et al. 2008; Cai et al. 2003), whereas 
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Nfatc1 specifically marks the endocardial lineage (Wu et al. 2011; de la Pompa et al. 1998). 
Between the myocardial and endocardial components lies cardiac jelly, which is a layer of 
extracellular matrix (Little et al. 1989). Signals from the surrounding myocardium, including 
Bmp and transforming growth factor beta (Tgfb), induce epithelial-to-mesenchymal 
transition within the endocardial population, which leads to the formation of endocardial 
cushions (Azhar et al. 2003; Kruithof et al. 2012; Brown et al. 1996; Eisenberg and 
Markwald 1995; Potts and Runyan 1989). The endocardial cushion further forms the 
membranous parts of the outflow tract, atrial and ventricular septa, the tricuspid valve and the 
mitral valve (Kruithof et al. 2012). 
During heart looping around 22 to 23 DPC, the epicardial cells start to populate the outer 
surface of myocardium generating the epicardium (Sylva et al. 2013). Epicardial cells 
originate from the pro-epicardial organ located on the inflow tract side of the heart, and the 
epicardial precursors are specifically marked by Tbx18 and Wt1 expression (Meilhac and 
Buckingham 2018). The origin of the pro-epicardial organ cells has been unclear, but a recent 
single-cell RNA sequencing study identified a novel Mesp1-mesoderm-derived progenitor 
population (juxta-cardiac field), which gives rise to both cardiomyocytes and epicardial cells 
(Tyser et al. 2021). In addition to covering the heart, epicardial cells give rise to cardiac 
interstitial fibroblasts, smooth muscle and endothelial cells of coronary arteries, valvular 
interstitial cells and annulus fibrosus, i.e. the fibrous tissue insulating atrial and ventricular 
electrical currents (Dettman et al. 1998; Mikawa and Gourdie 1996; Perez-Pomares et al. 
1997; Poelmann et al. 1993). Most of the cardiac fibroblasts, especially the cardiac interstitial 
fibroblasts, originate from a subpopulation of the epicardial cells undergoing epithelial-to-
mesenchymal transition, although some are generated by the cardiac neural crest and 
endocardium (Meilhac and Buckingham 2018; Ivey and Tallquist 2016; Ali et al. 2014). 
Cardiac neural crest is a multipotent migratory progenitor population marked by Wnt1-
expression, which differentiates into smooth muscle at the base of the large vessels, 
connective tissue and neurons of outflow tract, fibroblasts of the right atrium, 
aorticopulmonary ridge and cardiac parasympathetic nervous system, as well as contributes to 
the cardiac septa and mesenchyme of the aortic and pulmonary valves (Kirby et al. 1983; 
Bergwerff et al. 1998; Creazzo et al. 1998; Jiang et al. 2000; Jain et al. 2011). Retrovirus 
labelling has indicated, that neural crest cells gradually migrate to the heart region, first 
populating the outflow tract septum and pharyngeal arch arteries, and later contribute to the 
remodeling of the proximal pharyngeal arch arteries (Boot et al. 2003). Contributions of the 
neural crest to heart and large vessel development can be summed up in three main points 
based on neural crest ablation studies: 1) it participates in building the septum of the cardiac 
outflow tract (Kirby et al. 1983), 2) modulates FGF signaling, which affects both pharyngeal 
and heart development (Farrell et al. 2001), and 3) is indirectly involved in the recruitment of 
SHF contributing to outflow tract elongation (Yelbuz et al. 2002; Waldo et al. 2005).  
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2.5 CARDIAC PATTERNING AND MORPHOGENESIS 
The above mentioned lineages contribute to the complex events following the formation of a 
simple heart tube, and subsequent cardiac patterning and morphogenesis. Regional gene 
expression, as well as the hemodynamic forces generated by the beating heart tube and blood 
circulation contribute to the development of cardiac chambers, valves and conduction system. 
The specific properties of cardiomyocytes in the different heart compartments are established 
by differential gene expression of transcription factors, signaling molecules, structural 
proteins and ion channels (Sylva et al. 2013; Christoeffels et al. 2000; Bruneau 2013). In 
particular, a group of T-box transcription factors contribute to cardiomyocyte fate 
determination and patterning of cardiomyocytes with different electrophysiological properties 
(Sylva et al. 2013), whereas the anterior-posterior patterning, i.e. atrial and ventricular 
separation, is established by retinoic acid-induced Hox genes (Bertrand et al. 2011). 
Corresponding to the fourth week of human development, the heart tube elongates as a result 
of SHF migration, and starts to bend into an S-shape. Simultaneously with the elongation, 
rightward looping of the heart tube begins, as does ballooning and development of the future 
ventricles (Sylva et al. 2013). Soon after ventricular and atrial ballooning, septation starts to 
separate the four cardiac chambers. The cardiac septa are composed of both muscular and 
membranous parts (Franco et al. 2006; McFadden et al. 2005; Habets et al. 2002), and defects 
in septation are common representations of CHD, often affecting the membranous part of 
cardiac septa (Murray 1948). Towards the end of the sixth WPC, the ventricles, atria and 
outflow tract of the human heart are separate structures located in their final positions, but 
will continue to grow and mature (Sylva et al. 2013). 
The cardiac outflow tract develops from a myocardial tube into separate pulmonary and 
aortic outlets from 25 to 48 DPC in the human developmental timescale (Sylva et al. 2013). 
At the early stages of heart development, the outflow tract wall is exclusively composed of 
myocardium, whereas the lumen contains the cardiac jelly and endocardium which will give 
rise to the outflow tract cushions (Anderson et al. 2016). The outflow tract elongates as a 
result of SHF migration, and as the development proceeds, SHF continues to add both 
myocardial and non-myocardial components to the outflow tract (Kelly et al. 2001; Mjaatvedt 
et al. 2001; Waldo et al. 2001; Cai et al. 2003; Rana et al. 2014). Migration of cells from the 
neural crest into the heart is crucial for the outflow tract development, and is regulated by 
Wnt, Bmp, Fgf and Semaphorin signaling (Stoller and Epstein 2005). Within the outflow 
tract lumen, neural crest derivatives and the endocardial cushions build a septum as well as 
the semilunar valves (De Lange et al. 2004). The septum undergoes a 180˚ counterclockwise 
rotation in a spiral-like motion, resulting in the formation of the two large cardiac vessels. In 
particular, the SHF adds myocardial cells to the spiraling outflow tract, which is required for 
the appropriate alignment of the aorta and pulmonary trunk relative to the left and right 
ventricles (Ward et al. 2005). Following the fusion of the outflow tract cushions, the aorta 
and pulmonary trunk get separated gradually in distal to proximal order. Furthermore, 
remodeling of three pairs of pharyngeal arch arteries (3rd, 4th and 6th) contributes to the final 
morphology of the aortic arch and pulmonary trunk. (Anderson et al. 2016; Sylva et al. 2013) 
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In addition to Tgfb and Bmp which regulate the epithelial-to-mesenchymal transition of 
cardiac cushions, Vegf and its downstream Notch signaling pathways play an important role 
in the outflow tract septum development, by regulating both endocardium and the SHF 
myocardium (Dor et al. 2001; van den Akker et al. 2012; Niessen and Karsan 2008).   
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3 CONGENITAL HEART DEFECTS 
3.1 INTRODUCTION TO CONGENITAL HEART DEFECTS 
Cardiogenesis is established by a series of events involving integration of multiple cell types, 
and dysregulation of these processes results in morphological defects. CHD is the most 
common type of birth anomaly, affecting approximately 1% of newborns (Shabana et al. 
2020; Liu et al. 2019; van der Linde et al. 2011, Hoffman et al. 2002), and has the estimated 
prevalence of 2-3% (Pierpont et al. 2018). When including stillbirths that are caused by 
severe CHD, the percentage of CHD cases is significantly higher (Marelli et al. 2014; 
Hoffman 1995). The reported total CHD prevalence, especially that of mild congenital 
cardiac lesions, has increased over time due to improved clinical diagnostics and treatment 
options. As a consequence of increased survival beyond childhood, there are more adults than 
children with CHD, which has important implications for the modern societies (Liu et al. 
2019; Marelli et al. 2014, van der Linde et al. 2011). The manifestations of CHD include a 
range of cardiac malformations, the most common types globally being ventricular and atrial 
septal defects, patent ductus arteriosus, pulmonary stenosis, Tetralogy of Fallot and 
transposition of the great arteries (Liu et al. 2019; van der Linde et al. 2011). Because of its 
frequency and impact on the life of the patients, CHD is an important health concern and 
branch of cardiovascular research. 
Exposure to environmental factors, such as maternal retinoic acid intake, diabetes, smoking 
and exposure to medications and chemicals are implicated in both CHD and other common 
developmental defects, such as spina bifida and cleft lip and palate (Zhu et al. 2009; Hinton 
2013; Jenkins et al. 2007). However, cardiogenesis is particularly sensitive to genetic 
disturbances, and many epidemiological studies have established that genetics is the main 
factor behind CHD pathogenesis (Shabana et al. 2020). Large epidemiological studies 
indicate, that a single genetic cause is identified in only 20-30% of CHD patients, whereas a 
large portion of the cases is caused by rare variants and combinations of damaging mutations 
(Pierpont et al. 2018, Cowan and Ware 2015). In other words, CHD is characterized by a 
highly complex and contextual genetic landscape. 
3.2 GENETIC MECHANISMS 
Approximately 400 genes have been attributed to CHD (Williams et al. 2019). The disease-
causing variants affect a heterogeneous group of genes, in particular those coding for 
transcription factors, signaling and adhesion molecules, structural proteins, chromatin 
modifiers and cilia (Nees and Chung 2020), which can interfere with normal progenitor 
specification, differentiation, migration and patterning. Although a large number of gene 
variants have been shown to cause heart anomalies, the mechanisms that underlie the 
genotype-phenotype connection remain unclear for many types of complex CHD.  
A specific case of CHD can be 1) monogenic or polygenic, meaning that the phenotype is 
caused by only one genetic mutation or a combination of several genetic mutations, 2) 
syndromic or non-syndromic, meaning that the cardiac phenotype can appear in combination 
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with extracardiac anomalies or alone, as well as 3) familial or sporadic, meaning that the 
susceptibility gene mutation and cardiac phenotype run in the family following Mendelian 
heritage, or the patient phenotype is caused by a rare recessive or de novo mutation in a 
proband whereas the parents are unaffected (Fahed et al. 2013). Majority of the CHD cases, 
about 80%, are non-syndromic (Nees and Chung 2020). Furthermore, CHD cases are 
predominantly sporadic, and major part of the sporadic CHD cases is estimated to be 
explained by de novo damaging mutations (Shabana et al. 2020). 
Genetic variants can be divided into structural variants and point mutations (Shabana et al. 
2020). Structural variants include chromosomal aneuploidies and copy number variants. 
Trisomy 13, 18 and 21 are examples of chromosomal aneuploidies which are characterized 
by a range of phenotypes affecting the heart and other organ systems (Calcagni et al. 2017). 
The abnormal number of chromosomes in these patients causes changes in the expression 
dosage of thousands of genes (Wimalasundera and Gardiner 2004). The literature gives 
multiple definitions for copy number variants, but in general it can be said that they are 
sequences of deletions or multiplications. Due to often affecting the expression of multiple 
genes, copy number variants are commonly associated with syndromic CHD, but can also 
cause non-syndromic forms (Nees and Chung 2020).  
Point mutations can be either single nucleotide polymorphisms or insertions and deletions 
(indels) of short sequences, and cause both syndromic or non-syndromic forms of heart 
disease. Moreover, both coding and non-coding point mutations can cause CHD (Richter et 
al. 2020). When in the coding region, small mutations can cause a frameshift leading to a 
premature stop codon or disrupt important functional sites. Single nucleotide polymorphisms 
can also be non-synonymous, changing the amino acid sequence or synonymous which might 
affect the post-transcriptional processing of the mRNA molecule. The role of damaging 
variants within the non-coding regions in CHD is not yet well understood, but mutations in 
splice junctions and splice enhancers, sequences regulating RNA homeostasis and 
localization, regulatory RNAs, promoters, and enhancers can lead to dysregulation of gene 
expression. (Chahal et al. 2019, Ward and Kellis 2012)  
The perturbations in heart development by damaging genetic mutations is often caused by 
haploinsufficiency, i.e. the mutation causes either loss of gene expression, decreased 
expression or decreased protein function (Fahed et al. 2013). Less frequently, a mutation can 
lead to increased gene activity, which nevertheless can be equally damaging for cellular 
functions as loss of function mutations (Shabana et al. 2020). 
Disease-causing gene mutations sometimes interact with other stochastic genetic and 
environmental factors modifying the patient phenotype, although the molecular mechanisms 
behind these interactions are not well understood (Akhirome et al. 2017; Gifford et al. 2019). 
For example, the length of the DiGeorge associated 22q11.2 microdeletion does not directly 
correlate with the patient phenotype, which, instead, is likely determined by genetic modifiers 
in other genomic loci (Aggarwal et al. 2008). Furthermore, damaging mutations in several 
different genes can produce the same cardiac phenotype, and the same mutation in two 
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individuals may not cause the same heart defect (Shabana et al. 2020). It will be the challenge 
for the coming decades to understand how molecular pathways and gene families interact 
with different modifiers and genetic backgrounds to result in specific patient phenotypes 
(Jenkins et al. 2007, Zhu et al. 2009). 
3.3 RECENT GENOME-WIDE CARDIAC COHORT STUDIES 
Next-generation sequencing-based genetic studies have rapidly identified numerous novel 
disease-associated genes and gene variants. The next-generation sequencing approaches 
include whole-exome sequencing and whole-genome sequencing, which cover genetic 
variations within the coding genome or the complete genome, respectively. 
A recent large whole-exome sequencing study by the Pediatric Cardiac Genomic Consortium 
(PCGC) mapped novel damaging rare and dominant inherited and de novo mutations in a 
cohort of 2,871 CHD probands, including 2,645 family trios (Jin et al. 2017), being the most 
comprehensive published genetic study on a single CHD cohort to date. Among other 
findings, the study reported a recessive founder mutation in GDF1 accounting for ~5% of 
severe CHD in Ashkenazim population, recessive MYH6 variants accounting for ~11% of 
Shone complex cases, and dominant mutations in FLT4 accounting for ~2% of Tetralogy of 
Fallot (Jin et al. 2017). Despite the large number of patients included in the study, it only 
covers a fraction of the total genetic causes of CHD. Sifrim et al. estimated that whole-exome 
sequencing of ~10,000 family trios would be needed to cover most of the dominant CHD-
associated genes (Sifrim et al. 2016, Jin et al. 2017).  
The first large whole-genome sequencing trio study included 749 CHD probands with 
parents, and used neural network prediction and enhancer analysis to identify potentially 
damaging mutations within the non-coding genome (Richter et al. 2020). The study identified 
non-coding variants within human fetal cardiac regulatory regions based on H3K27ac 
chromatin immunoprecipitation of human fetal cardiac tissue, and functionally validated 
selected mutated regulatory sequences by massively parallel reporter assay, a high-throughput 
platform for measuring regulatory activity of thousands of normal and mutated regulatory 
DNA sequences in parallel in an in vitro system (Melnikov et al. 2014). The study established 
that non-coding de novo variants significantly contribute to CHD pathogenesis, but points out 
that the genetic mechanisms remain to be explored. Several high-throughput technologies can 
be used to navigate the often cell type-specific functional implications of non-coding variants, 
including ChIP-seq, RNA-seq, ATAC-seq, DNAse-seq, MNase-seq and FAIRE-seq (Chahal 
et al. 2019). 
3.4 MALFORMATIONS OF THE CARDIAC OUTFLOW TRACT 
Defects in the outflow tract development represent approximately 30% of all CHD cases 
(Thom et al. 2006). Since the outflow tract development requires precise coordination of 
migratory progenitor populations of the SHF, endocardium and cardiac neural crest to 
establish elongation, septation, rotation and separation of the large vessels, genetic mutations 
impairing the function of any of these lineages may lead to disturbances in the morphogenetic 
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patterning of the outflow tract (Neeb et al. 2013). The major abnormalities of the outflow 
tract found in patients are: 
Persistent truncus arteriosus (PTA): The aorta and the pulmonary trunk are not completely 
separated. Appears always together with atrioventricular septal defect. 
Double outlet right ventricle (DORV): Both the aorta and pulmonary trunk are connected to 
the right ventricle as a result of partially failed outflow tract rotation. DORV always occurs 
with a ventricular septal defect connecting the ventricles. 
Transposition of the great arteries (TGA): The aorta exits the right ventricle and the 
pulmonary trunk exits the left ventricle as a result of failed outflow tract rotation. 
Tetralogy of Fallot: Misaligned outflow tract with associated overriding aorta, pulmonary 
stenosis, right ventricular hypertrophy and ventricular septal defect. (Neeb et al. 2013) 
Other outflow tract -related anomalies include coarctation of the aorta, vascular ring, aberrant 
subclavian artery, pulmonary stenosis, patent ductus arteriosus, persistent left superior vena 
cava, anomalous pulmonary venous connection and various outflow tract valve deformities 
(Neeb et al. 2013). The disease mechanisms behind these malformations are not completely 
understood. 
3.5 TETRALOGY OF FALLOT 
3.5.1 Introduction to Tetralogy of Fallot 
Tetralogy of Fallot represents 7-10% of all CHD cases (Ferencz et al. 1985; Bailliard and 
Anderson. 2009) and mainly affects the right ventricular outflow tract. The condition 
manifests as a combination of four cardiac structural abnormalities: pulmonary outflow tract 
obstruction (either infundibular narrowing or pulmonary valve stenosis), ventricular septal 
defect, overriding aorta, and right ventricular hypertrophy (Fallot. 1888) (Figure 2). Although 
described as four separate structural malformations, the phenotype has one cause, as the 
misaligned outflow tract is mainly responsible for the pulmonary outflow tract obstruction, 
ventricular septal defect and overriding aorta, and right ventricular hypertrophy is the 
consequence of the hemodynamic changes caused by these structural defects (Wiputra et al. 
2018; Bailliard and Anderson 2009; Andreson and Weinberg. 2005; Van Praagh et al. 1970). 
From the cell biology perspective, the failure of the SHF progenitors to muscularize the 
outflow tract is a central issue in the Tetralogy of Fallot pathophysiology (Bailliard et al. 
2009).  
Cyanosis, caused by deoxygenated blood from the right ventricle entering the systemic 
circulation through aorta, is the clinical hallmark of Tetralogy of Fallot pathology. 
Consequently, the blood oxygen saturation is low, which can be observed as a bluish skin 
color of infants suffering from Tetralogy of Fallot (Figure 2). The Tetralogy of Fallot 
anatomy varies between patients, and the classical form of Tetralogy of Fallot is often seen 
together with other anomalies including pulmonary atresia, absent pulmonary valve, DORV, 
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atrioventricular septal defect, atrial septal defect and right aortic arch (Bailliard and 
Anderson. 2009). Tetralogy of Fallot patients usually undergo corrective surgery soon after 
birth, ideally within the first 12 months, and the choice of surgical intervention is determined 
by the severity of the cardiac phenotype (Bailliard and Anderson. 2009). Complete cardiac 
repair involves insertion of two patches; one to close the opening between ventricles and one 
to reconstruct the right ventricular outflow tract area (Kurosawa et al. 1988; Kurosawa et al. 
1998). In the palliative surgical option, shunts are generated to connect systemic and 
pulmonary circulation (Sharkey and Sharma 2012). The corrective surgery can lead to 
complications, and even after successful intervention many patients suffer from persistent 
arrhythmias and dysfunction of the right ventricle due to backflow of blood from the 
pulmonary artery back into the right ventricle (Kurosawa et al. 1998). However, before the 
surgical correction was introduced in 1955, the mortality of untreated Tetralogy of Fallot 
patients was 50% in the few first years of life, which has dropped significantly with the 
development and improvement of surgical interventions (Apitz et al. 2009). 
 
Figure 2. The major characteristics of Tetralogy of Fallot. Created with BioRender.com. 
3.5.2 Genetics of Tetralogy of Fallot 
The etiology of Tetralogy of Fallot is not completely understood, but in the light of present 
evidence, genetic predisposition plays a significant role in the disease pathogenesis 
(Morgenthau and Frishman 2018). The reason for uncertainty about the etiology of Tetralogy 
of Fallot and other complex CHD is that they are multifactorial, with both complicated 
genetics and involvement of environmental risk factors. 
Several sequencing studies have identified genetic mutations affecting members of NOTCH 
and VEGF signaling pathways, particularly the VEGF receptors FLT4 and KDR, as well as 
NOTCH1, NOTCH2 and JAG1 from the NOTCH family, as primary candidates in the 
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pathogenesis of Tetralogy of Fallot (Reuter et al. 2019; Jin et al. 2017; Page et al. 2019). The 
VEGF pathway has been long known to play an important role in cardiovascular 
development (Carmeliet. 2000; Ferrera et a. 2003; Ylä-Herttuala et al. 2007). NOTCH 
signaling is closely intertwined with the VEGF pathway, being one of its main downstream 
pathways (Lawson et al. 2003; van den Akker et al. 2012). The importance of NOTCH and 
VEGF in Tetralogy of Fallot pathology is also supported by their eminent, but not completely 
understood, role in the development of the cardiac outflow tract (van der Akker et al. 2012). 
In addition to signaling molecules, several transcription factors have been implicated in the 
pathogenesis of Tetralogy of Fallot. Much of the current knowledge about the role of certain 
transcription factors in Tetralogy of Fallot genetics comes from familial studies. For example, 
damaging mutations in GATA4, TBX5 and NKX2-5 have been found to result in familial 
isolated Tetralogy of Fallot in several instances (Dixit et al. 2018; Yang et al. 2013; 
Goldmuntz and Benson, 2001; Benson et al. 1999). The transcription factor-coding genes 
mentioned here are but a few examples, and many more have been implicated in the 
Tetralogy of Fallot phenotype, including TBX1, FOXC1, FOXC2, FOXH1, HAND2, ZFPM2 
and others (Morgentha and Frishman. 2018; Töpf et al. 2014; Zhang et al. 2014). 
Approximately 20-30% of Tetralogy of Fallot cases are associated with genetic syndromes 
and rare diseases, including DiGeorge, Trisomy 21 (or Down syndrome), CHARGE, Opitz, 
Cantrell, Trisomy 22, Alagille, Goldenhar, Sotos, Torell, Noonan, Williams, Waarndenburg, 
Kabuki, Klippel Feil and cystic fibrosis (Morgenthau and Frishman 2018; Digilio et al. 1996). 
Despite the diversity of genetic syndromes associated with Tetralogy of Fallot, the genetics of 
syndromic cases is relatively better understood than that of the non-syndromic cases. Both 
mutations in the TBX1 gene and its deletion or duplication in the 22q11.2 locus, which 
includes TBX1 and other genes, in DiGeorge syndrome usually manifest with Tetralogy of 
Fallot (Merscher et al. 2001; Lindsay et al. 2001; Hasten et al. 2018). DiGeorge syndrome is 
strongly linked with the haploinsufficiency of TBX1 and other genes within the associated 
locus, but mutations in other genetic loci have been found to modify the phenotype (Du et al. 
2020). As another example, heterozygous mutations in JAG1 and NOTCH2 genes cause 
Alagille syndrome, and similar to DiGeorge, the phenotypic penetrance varies between 
patients (Mitchell et al. 2018; McDaniell et al. 2006). In the light of cohort studies, 
approximately 3-4% of Down syndrome patients suffer from Tetralogy of Fallot (Stoll et al. 
2015; Källén et al. 1996).  
The majority of Tetralogy of Fallot cases are isolated, and the genetic etiology of isolated 
Tetralogy of Fallot is complex and characterized by a plethora of rare genetic variants, which 
is true for isolated CHD in general (Nees and Chung. 2020). Discovery of genes causing non-
syndromic Tetralogy of Fallot is largely facilitated by whole-exome and whole-genome 
sequencing studies based on large and clinically well-defined patient cohorts. The largest 
such study to date included whole exome sequencing of 829 non-syndromic Tetralogy of 
Fallot patients, and found that 7% of the study subjects harbored deleterious variants in 
NOTCH1 and FLT4 loci (Page et al. 2019). 
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3.5.3 Modeling the pathophysiology 
Early embryonic manipulation studies, in particular using chick embryos as a model, revealed 
the importance of the SHF and neural crest in the outflow tract morphogenesis. These studies 
revealed that removal of the neural crest population before its migration to the outflow tract 
disrupts the formation of the aorticopulmonary septum leading to either common arterial 
outflow tract channel (i.e. PTA) or TGA (Kirby et al. 1983). Furthermore, neural crest plays 
another important indirect role in the outflow tract morphogenesis, as signaling by the neural 
crest is required for the recruitment of the SHF-derived myocardium into the developing 
outflow tract (Waldo et al. 2005). Consequently, the SHF fails to add cells to the outflow tract 
myocardium in chick embryos after cardiac neural crest ablation (Waldo et al. 2005). It was 
also shown that the direct disruption of the outflow tract-destined SHF population induces a 
variety of outflow tract malformations including TGA as well as reduced size of the 
pulmonary trunk, which is the hallmark of Tetralogy of Fallot pathogenesis (Ward et al. 
2005).  
Several genetically engineered mouse models have been developed to study specific cell 
lineages contributing to outflow tract development. For example, global deletion of Tfap2a 
(Brewer et al. 2002) and Cited2 (Bamforth et al. 2001) affects the cardiac neural crest 
specification; deletion of Pitx2 (Ai et al. 2006) and Smad4 (Azhar et al. 2010) affects outflow 
tract myocardium; and deletion of Nrp1 (Kawasaki et al. 1999) or Sox4 (Schilham et al. 
1996) affects outflow tract endothelium and endocardium. Moreover, various Cre 
recombinase mice have been generated for studies investigating the lineages contributing to 
outflow tract development. For instance, mice with Cre-knockin in the Wnt1 (Jiang et al. 
2000) and Tfap2a (Macatee et al. 2003) loci have been used to study the neural crest lineage; 
in Isl1 (Park et al. 2006) and Nkx2-5 (Lints et al. 1993) loci to study the myocardial lineage; 
and in Tie1 (Gustafsson et al. 2001) and Kdr (Motoike et al. 2003) loci to study the 
endocardial lineage. 
Multiple loss- and gain-of-function mouse models show the pathophysiology similar to 
human Tetralogy of Fallot (Snider and Conway 2011), and have revealed a few different 
explanations for the outflow tract phenotype. However, as human patients, genetically 
engineered mice usually show a spectrum of cardiac phenotypes despite sharing the same 
genotype. For example, Hey2 knockout mice, which codes for a transcription factor 
modulating Notch signaling, display a variety of heart malformations including Tetralogy of 
Fallot (Donovan et al. 2002). Similarly, knockout and/or haploinsufficiency studies on Nkx2-
5, Tbx1 and Jag1 have confirmed their role in outflow tract morphogenesis and Tetralogy of 
Fallot pathogenesis (Ashraf et al. 2014; Rana et al. 2014; Hofmann et al. 2012). In 
VEGF120/120 knockin mice (which only express the VEGF120 isoform), a localized 
increase of Vegf signaling in the SHF-derived outflow tract myocardium leads to 
perturbations in Notch signaling and outflow tract cushion hypoplasia. This mouse model has 
been shown to produce the Tetralogy of Fallot phenotype with high penetrance (Rammeloo et 
al. 2015; van den Akker et al. 2007). Furthermore, knockout of Zfpm2 gene, a co-factor of 
Gata transcription factors, produces a Tetralogy of Fallot-like phenotype in mice, but also is 
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embryonic lethal and is accompanied by various extracardiac defects (Tevosian et al. 2000). 
These animal models have verified that the decreased outflow tract elongation causes the lack 
of counterclockwise rotation of the outflow tract cushions, which is the root of Tetralogy of 
Fallot pathogenesis (Snider and Conway 2011; Restivo et al. 2006). These examples further 
illustrate, that disturbances in various developmental mechanisms can cause the typical 
Tetralogy of Fallot phenotype, which applies to human Tetralogy of Fallot patients as well as 
mouse models. 
In addition to animal models, cardiac differentiation of hPSCs has been increasingly used as a 
human-based alternative to study CHD (Matsa and Denning 2012; Ye et al. 2018; Shaheen et 
al. 2017). In particular, the development of the CRISPR/Cas9 system (Torres-Ruiz and 
Rodriguez-Perales 2017) has enabled efficient induction and correction of patient-specific 
mutations in hPSCs. In a recent study, Grunet and colleagues generated patient-specific 
induced pluripotent stem cells (iPSCs) from dermal fibroblasts collected from two patients 
with non-syndromic Tetralogy of Fallot (Grunet et al. 2020). Upon in vitro cardiac 
differentiation in a 2D culture system, the patient iPSC-derived cells showed significant 
decrease in the expression of cardiac transcription factors (e.g. ISL1 and HES1), genes 
belonging to the NOTCH signaling pathway (e.g. JAG1), cell-cell adhesion molecules (e.g. 
DSG2) and several collagen-coding genes compared to the iPSCs derived from healthy 
controls. Another study showed, that pathogenic mutations of the NOTCH signaling-related 
gene ADAM17 found in Tetralogy of Fallot patients induced hypertrophy of hESC-derived 
cardiomyocytes (Xie et al. 2019). The phenotype of ADAM17 mutant cells was related to 
disturbances in heparin-binding EGF-growth factor signaling (Xie et al. 2019), which has 





4 SINGLE-CELL TRANSCRIPTOMICS AND HEART 
DEVELOPMENT 
Single-cell transcriptomics provides an approach with great resolution and throughput for 
studying the patterns of gene expression that define the different stages of cardiac lineage 
development, and has facilitated the identification of novel and rare cell types in pre- and 
post-natal human hearts (Paik et al. 2020). To set the main stage of my thesis work, I will 
here give an overview of the current single-cell coverage of the pre-natal heart development 
with notes to the cell composition in mouse and in the adult human heart. 
4.1 SINGLE-CELL ANALYSIS OF EARLY MOUSE HEART 
The mouse model for early embryonic development is well established, and single-cell 
studies on mouse embryos have investigated the genetic regulation from implantation to 
gastrulation between embryonic day (E) 3.5 to 6.5 (Mohammed et al. 2017); conversion of 
pluripotent cells to Mesp1-expressing mesoderm around gastrulation at E6.25, 6.5 and 7.25 
(Lescroart et al. 2018; Scialdone et al. 2016); lineage commitment of Isl1- and Nkx2-5-
expressing populations through E7.5 to 9.5 (Jia et al. 2018); spatial specification of cardiac 
progenitors at E8.5, 9.5 and 10.5 (Li et al. 2016); and the anatomical maturation of primordial 
heart tube at E9.5 into a fully developed heart at post-natal day 21 (DeLaughter et al. 2016). 
Combining gene ablation with single-cell analysis, recent studies have elucidated the specific 
roles of Hand2 in heart development and outflow tract defects covering E7.75 and 8.25 (de 
Soysa et al. 2019) and Pitx2 in both heart fields at E10.5 and 13.5 (Kadow et al. 2019). 
Furthermore, single-cell analysis of the outflow tract cell types by Liu and colleagues, with 
an emphasis on smooth muscle cell development and trans-differentiation of myocardium to 
smooth muscle, provides a reference of the normal outflow tract development for studies on 
conotruncal heart defects (Liu et al. 2019). Interestingly, a very recent single-cell study 
characterized a common progenitor of cardiomyocytes and epicardium, which differ 
anatomically and transcriptionally from the FHF and SHF progenitors (Tyser et al. 2021). 
4.2 SINGLE-CELL ANALYSIS OF PRE- AND POST-NATAL HUMAN HEARTS 
Recent single-cell studies have covered the early heart development of embryonic 4.5 to 9 
WPC stages (Sahara et al. 2019; Cui et al. 2019; Asp et al. 2019) and fetal cardiogenesis from 
9 to 25 WPC (Sahara et al. 2019; Suryawanshi et al. 2020; Cui et al. 2019). In paper III, we 
present single-cell analysis of seven pre-natal human hearts ranging from 4.5 to 10 WPC.  
Cui and colleagues (Cui et al. 2019) studied human developing hearts ranging from 5 to 25 
WPC. They identified different transcriptional profiles between spatial subsets of 
cardiomyocytes including compact and trabecular as well as atrial and ventricular 
cardiomyocytes. Furthermore, pseudotemporal analysis of the cardiomyocyte trajectory 
showed dynamic change in specific gene modules, especially in extracellular matrix-related 
gene expression. In addition to cardiomyocytes, development of cardiac fibroblasts, valvular 
and endothelial cells was characterized, and finally the human cell populations were 
compared with their counterparts in mouse at several developmental time points. Across the 
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compared cell types, cardiomyocyte transcriptomes showed highest level of conservation 
between species. 
Asp and colleagues (Asp et al. 2019) studied 4.5-5, 6.5 and 9 WPC human embryos using 
spatial transcriptomics approach and 6.5-7 WPC embryos using single-cell RNA sequencing. 
Compared to the study by Cui and colleagues, this study has fewer analyzed time points, but 
the annotation of cell types, especially different cardiac fibroblast populations, is more 
detailed. Combination of single-cell and spatial transcriptomics allowed Asp and colleagues 
to specify the spatial subpopulations, for example distinguishing fibroblasts related to small 
and large vasculature and cardiac skeleton. In addition, a small population of cardiac neural 
crest cells was identified, which was not reported in other single-cell studies on human 
embryos. The whole dataset was converted into an online-based resource, which I have 
utilized in my projects. 
Recent single-cell analyses on later pre-natal time points by Suryawanshi and colleagues 
revealed the cellular composition in the more mature fetal heart. Single-cell analysis of the 
human fetal hearts and comparison between healthy fetal hearts at 19 to 22 WPC and a heart 
with congenital heart block at 21 WPC indicated some differences in transcriptional 
signatures, most notably in interferon-stimulated genes and genes related to fibrosis 
(Suryawanshi et al. 2020). As shown by Cui and colleagues, expression of extracellular 
matrix genes is an integral part of normal heart development, whereas it can also be a 
hallmark of CHD, as shown by Suryawanshi and colleagues. 
Compared to pre-natal human heart, the cellular composition of the adult human heart has 
been less studied using single-cell RNA sequencing. One reason for the lack of single-cell 
studies on human adult heart is that the currently popular high throughput microfluidics-
based single-cell platforms do not support cells as large as adult human cardiomyocytes. 
Tucker and colleagues (Tucker et al. 2020) and Litviňuková and colleagues (Litviňuková et 
al. 2020) circumvented this issue by isolating single cardiac nuclei, and both groups 
sequenced around 300 000 nuclear transcriptomes each. These studies together provide a cell 
type atlas of the normal adult human heart, which is useful for understanding mechanisms 
behind adult-onset heart disease. Furthermore, Wang and colleagues (Wang et al. 2020) used 
single-cell sequencing to compare cardiomyocytes and non-cardiomyocytes in healthy, failed 
and recovering adult human hearts, and looked at differential cell composition, homeostasis 
and genetic networks in the different stages of cardiac disease. 
4.3 SINGLE-CELL ANALYSIS OF IN VITRO CARDIAC DIFFERENTIATION 
As shown in earlier clonal analyses and recent single-cell studies (Bu et al, 2009; Ruan et al. 
2019; Friedman et al. 2018; Churko et al. 2018), in vitro cardiac differentiation generates 
both cardiomyocyte and non-cardiomyocyte lineages (Figure 3). Hence, interactions and 
developmental relationships between these cell types during early development can be 
studied in vitro, which is greatly facilitated by single-cell RNA sequencing. A few labs, 
including ours, have employed the small molecule mediated Wnt-modulation based cardiac 
20 
differentiation of hPSCs for single-cell analysis of in vitro cardiogenesis (Ruan et al. 2019; 
Friedman et al. 2018; Churko et al. 2018; Lian et al. 2012). 
Figure 3. Cardiac in vitro differentiation generates cardiomyocytes and other cell types. 
Created with BioRender.com. 
The study by Friedman and colleagues (Friedman et al. 2018) was the first one to analyze 
multiple time points of cardiac differentiation based on this protocol in single-cell resolution. 
They identified cardiac progenitors and cardiomyocytes, but also endoderm and outflow 
tract-like cardiac fibroblasts. The study further identified maturation and hypertrophy-related 
genetic programs down-regulated in the in vitro differentiation system, among which HOPX 
was highlighted and further validated. 
Focusing on transcription factor hierarchies, Churko and colleagues (Churko et al. 2018) 
sequenced cells from days 0, 5, 14 and 45 of the cardiac differentiation and identified a 
multitude of cell types, including both atrial and ventricular cardiomyocytes, endoderm, 
ectoderm and neural crest-like cells. The study suggests that the three transcription factors, 
TBX5, NR2F2 and HEY2, regulate the electrophysiological properties of different 
cardiomyocyte subtypes found in the in vitro differentiation. 
Ruan and colleagues (Ruan et al. 2019) sequenced cells from time points 2, 5, 9 and 14, and 
focused on the signaling between cardiomyocytes and the endoderm cells found in the in 
vitro cardiac differentiation. Based on differential gene expression in cardiac progenitors, 
Ruan and colleagues concluded that ETS1 is an important transcription factor regulating 
cardiac differentiation and dependent on the crosstalk between cardiac progenitors and 
endoderm. However, ETS1 is only expressed by endothelial cells in our single-cell dataset, 
which highlights the differences between different datasets and data interpretation. 
To conclude, the recent single-cell RNA sequencing studies by us and other laboratories have 
clarified the cellular heterogeneity and developmental paths of the hPSC-based cardiac 
differentiation. These new insights are important steps towards comprehensive understanding 




5 RESEARCH AIMS 
The overall aim of this thesis is to gain new insights into the development of early cardiac 
progenitors, and to apply this knowledge to advance the understanding of CHD pathogenesis. 
The specific aims of the constituent papers are as follows: 
Paper I: To build a roadmap of cardiac progenitors through single-cell analysis of hESC to 
cardiomyocyte differentiation, identify human fetal counterparts of myogenic and non-
myogenic populations arising during the differentiation, and to investigate the role of ISL1 in 
the development of these cell populations. 
Paper II: To map the genetic landscape of non-syndromic Tetralogy of Fallot by whole-
genome sequencing, and to use integrative analysis to pinpoint enrichment of disease-
associated gene expression among the single-cell transcriptomes of early cardiac cells. 
Paper III: To comprehensively interrogate cardiogenesis of hESCs and human 
embryonic/fetal heart by single-cell analysis, and thereby understand the cellular origins of 





6.1 HUMAN PLURIPOTENT STEM CELLS 
The hPSCs, which are often used in in vitro differentiation protocols, include 1) hESCs, 
derivatives of the inner cell mass of human blastocysts (Thomson et al. 1998, Evans and 
Kaufman 1981, Martin 1981), and 2) human induced pluripotent stem cells (hiPSCs), derived 
from somatic cells by direct reprogramming through expression of transcription factors 
OCT3/4, SOX2, MYC and KLF4 (Takahashi et al. 2007; Yu et al. 2007). Both types of hPSCs 
represent a pre-gastrulation stage of development, are capable of unlimited proliferation in an 
undifferentiated state, and are capable of generating derivatives of the three germ layers (Zhu 
and Huangfu 2013, Yu et al. 2007, Takahashi et al. 2007, Thomson et al. 1998). Maintenance 
of both types of hPSCs in an undifferentiated state requires either feeder cells, usually mouse 
embryonic fibroblasts, or a coating mimicking the extracellular matrix, such as Matrigel. 
Both of these alternatives contain xenogeneic components, and as a better alternative 
completely synthetic coating materials have been developed, allowing the use of hPSC 
derivatives in regenerative medicine applications (Villa-Diaz et al. 2013). 
One inherent challenge of hESCs and hiPSCs is the heterogeneity between cell lines, and 
their potentials to differentiate to different cell types (Hu et al. 2010; Osafune et al. 2008). For 
example, the hESC line ES08 is ideal for pancreatic differentiation, whereas ES03 is 
preferred for cardiac differentiation (Osafune et al. 2008). Heterogeneity between hiPSC lines 
is especially pronounced due to epigenetic memory of the tissue of origin, as well as the 
epigenetic and genetic scars generated during the direct reprogramming (Kim et al. 2010; 
Polo et al. 2010; Gore et al. 2011; Laurent et al. 2011; Lister et al. 2010). Consequently, 
hESCs may be a more robust source for directed differentiation. This opinion might be 
biased, and hiPSC have certain advantages, such as usage of patient-derived cells to study 
disease phenotypes. 
6.2 FROM STEM CELLS TO BEATING CARDIOMYOCYTES 
One of the main premises of my thesis is that hPSC cardiac differentiation recapitulates many 
aspects of early heart development ‘in a dish’. The in vitro cardiac differentiation protocols 
are designed to follow the signaling regulating lineage differentiation in an embryo, and the 
genetic programs taking place in hPSC cardiac differentiation follow a similar sequence in 
vitro as they do in vivo (Später et al. 2014; Mummery et al. 2012). 
The first achieved in vitro cardiac differentiations of hPSCs were based on embryoid bodies, 
spontaneously forming aggregates of hPSCs which can be directed towards different lineages 
by adding specific cues to the culture medium (Schuldiner et al. 2000; Kehat et al. 2001; 
Itskovitz-Eldor et al. 2000). However, embryoid bodies generate less than 10% 
cardiomyocytes (Kehat et al. 2001), and to improve the yield of cardiomyocytes, various 
protocols were developed adding for example mouse visceral endoderm-like cell conditioned 
medium (Xu et al. 2008) and exogenous defined growth factors mimicking mesoderm 
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inducing signals (Burridge et al. 2012; Kattman et al. 2011; Yang et al. 2008). Another 
approach for cardiac differentiation relied on co-culture with endodermal cells (Mummery et 
al. 2012). 
Monolayer-based approaches were developed as an alternative to the embryoid body-based 
cardiac differentiation, providing more defined differentiation conditions and higher 
cardiomyocyte yield. These protocols are typically based on addition of specific 
developmental cues at specific timepoints to the cell culture system to first direct the hPSCs 
towards one of the germ layers and thereafter specify the lineage. In growth factor-based 
method, activin A, bone morphogenic factor (BMP4), FGF2, VEGF and Dickkopf-1 (DKK-
1) are first added in RPMI/B27 medium to induce the formation of mesendoderm (Schuldiner 
et al. 2000; D’Amour et al. 2005). Thereafter, inhibition of canonical Wnt pathway directs the 
differentiation towards cardiac mesoderm (Lian et al. 2012). 
Small molecule-based modulation of canonical Wnt signaling pathway was introduced using 
GSK3 inhibitors with small-molecule inhibitors of Wnt ligand production (IWPs)/PORCN 
inhibitors (Burridge et al. 2012; Lian et al. 2013; Lian et al. 2012; Foo et al. 2018). This 
protocol is based on the notion that endogenous Wnt/β-catenin pathway is required for 
cardiac differentiation from hESCs (Paige et al. 2010; Lian et al. 2013). During embryonic 
development, Wnt signaling initially promotes cardiac differentiation, but later inhibits the 
progenitors from being differentiated into the cardiac derivatives (Naito et al. 2006; Kwon et 
al. 2007). Accordingly, an initial addition of GSK3 inhibitor allows the accumulation of β-
catenin into the cytoplasm and nucleus, where it acts as a coactivator of transcription factors 
in the TCF/LEF family, and activation of downstream targets, such as BRACHYURY/T, 
leading to induction of mesoderm formation (Showell et al. 2004). In the absence of the 
inhibitor, β-catenin is targeted by a destruction complex, which GSK3 is a part of, to 
ubiquitination and degradation by the proteosome. Alike the growth factor method, 
subsequent inhibition of Wnt ligand production by IWPs directs the differentiation towards 
cardiac mesoderm (Lian et al. 2013).  
Following these protocols, the differentiating cells follow genetic programs familiar from the 
in vivo cardiac differentiation. The cells stay in a pluripotent-like state expressing 
pluripotency markers OCT4 and SOX2 until they start expressing T, MIXL1 and MESP1 
related to mesoderm specification, followed by the sequence of ISL1, GATA4, NKX2-5 and 
TNNT2 expression, corresponding to cardiac progenitors, specified cardiac progenitors and 
early cardiomyocytes (Protze et al. 2019; Mummery et al. 2012; Kehat et al. 2001).  
When differentiated, both in vivo and hPSC-derived cardiomyocytes 1) contract through 
actions by sarcomere and calcium supply from the sarcoplasmic reticulum, 2) spontaneously 
depolarize through membrane-bound ion pumps and channels, and 3) are electrically coupled 
with other cardiomyocytes via gap junctions (Jiang et al. 2018; Foo et al. 2018; Parikh et al. 
2017).  However, the cardiac differentiation of hPSCs generates cardiomyocytes that are 
functionally and structurally different from adult cardiomyocytes (Jiang et al. 2018). The 
differences between in vitro-derived and human adult cardiomyocytes include size, 
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complexity of the t-tubule network, number of nuclei, gene expression, bioenergetics and 
electrophysiological properties, the in vitro-derived cardiomyocytes being closer to the 
embryonic- and fetal-like phenotype in these aspects (Robertson et al. 2013). In our study 
presented in paper I, we found that the day 15 hESC-derived immature cardiomyocytes 
resemble the 5-week human embryonic ventricular cardiomyocytes at single-cell level (Paper 
I, Figure 2). 
The choice of differentiation method can be based on several criteria, such as atrial versus 
ventricular phenotype. The small molecule modulation of canonical Wnt pathway has been 
shown to more robustly generate cardiomyocytes with the ventricular phenotype compared to 
the growth factor-based protocols (Lian et al. 2012). Furthermore, other protocols have been 
developed to differentiate hPSCs into atrial cardiomyocytes and pacemaker cells (Laksman et 
al. 2017; Lee et al. 2017; Protze et al. 2017), epicardial cells (Guadix et al. 2017), cardiac 
fibroblasts (Zhang et al. 2019), as well as endothelial and vascular smooth muscle cells 
(Patsch et al. 2015; Palpant et al. 2017). 
6.3 GENE EDITING 
Gene editing with minimal off-target effects is essential for the utilization of stem cells in 
studying development and congenital defects. In my current project, which has not yet 
reached the maturity to be included in this thesis, I study the role of one of the candidate 
genes identified in a Tetralogy of Fallot patient cohort in heart development through genetic 
manipulation of hESCs. In addition, we used genetic ablation of ISL1 expression to study its 
role in the differentiation of myogenic and non-myogenic progenitors in the in vitro cardiac 
differentiation system. 
Homologous recombination (HR), zinc finger nucleases (ZFNs) and transcription activator-
like effector nucleases (TALENs) have been widely used for gene editing in both in vitro and 
in vivo systems in academia and industry (Gordon et al. 1980; Smithies et al. 1985; Thomas 
et al. 1987; Kim et al. 1996; Urnov et al. 2010; Hockemeyer et al. 2011, Cong et al. 2013). 
Although important discoveries have been made using these methods, they involve a lengthy 
and complicated design, difficulty to avoid off-target effects and large expression vectors 
(Gupta and Musunuru 2014; Miller et al. 2011).  
Nowadays, the most popular method for precise gene editing is based on clustered regularly 
interspaced short palindromic repeats (CRISPR) and CRISPR-associated nuclease (Cas9) 
(Mali et al. 2013). Due to the great impact on genetic research and other fields, Emmanuelle 
Charpentier and Jennifer Doudna were awarded the 2020 Nobel prize in chemistry for their 
discovery of the CRISPR/Cas9 system. CRISPR/Cas9 is based on the adaptive immune 
system of bacteria and archaea, which utilizes Cas proteins in combination with guide RNAs. 
The guide RNAs are expressed from protospacers, foreign DNA sequences, which bacteria 
and archaea collect and incorporate in their own genomes. These foreign sequences are 
expressed as short RNAs with adapter sequences, which are recognized by the Cas protein 
 
26 
and bind to foreign DNA sequences, such as those of bacteriophages. Upon guided binding, 
the Cas protein catalyzes a cleavage and introduces a double strand break. (Jinek et al. 2012)  
ZFNs, TALENs and CRISPR/Cas9 systems introduce double strand breaks, which the DNA 
repair system mends by either nonhomologous end joining (NHEJ) or in the presence of a 
DNA template by homology-directed repair (HDR). NHEJ is an error prone process leaving 
small mutations often leading to a frame shift, which are useful for generation of gene 
knockouts. (Gupta and Musunuru 2014) On the other hand, HDR can be utilized to precisely 
induce specific mutations into the DNA sequence, which is often used to correct mutations in 
patient-derived hiPSC lines and knocking in reporter alleles (Ben Jehuda et al. 2018). The 
most commonly used Cas protein, Cas9, recognizes a sequence upstream to -NGG sequence, 
a protospacer adjacent motif (PAM). Mali et al. demonstrated bioinformatically, that there are 
approximately 190,000 possible target sequences, covering 40.5% of the human genome 
(Mali et al. 2013). Therefore, researchers are given a great freedom for designing gene edits.  
6.4 SINGLE-CELL RNA SEQUENCING 
If CRISPR/Cas9 is the state-of-the-art method for gene editing, single-cell RNA sequencing 
is the state-of-the-art method for gene expression analysis in cells and tissues. Brady et al. 
(1990) and Eberwine et al. (1992) published the pioneering work towards the development of 
the single-cell RNA sequencing technology by generating complementary DNA (cDNA) 
libraries from cells isolated from mouse bone marrow and rat hippocampus, respectively. The 
early single-cell RNA sequencing was based on high-density DNA microarray chips (Hwang 
et al. 2018), and the next-generation sequencing-based single-cell RNA sequencing first 
appeared in 2009, when it was applied to analyze the transcriptome of a single mouse 
blastomere (Tang et al. 2009). Li et al. (2016) and Kokkinopoulos et al. (2015) were among 
the first to report a single-cell analysis of murine heart development, revealing differences 
between in vitro and in vivo cardiac development. 
6.4.1 Single-cell library preparation and sequencing 
The single-cell RNA sequencing workflow (Figure 4) starts with isolation of single cells into 
a hypotonic lysis buffer, which can be carried out using various methods. Common single-
cell isolation methods include 1) dilution-based pipetting of cells in low concentration 
suspensions, 2) microscope-guided capillary pipet cell picking, 3) fluorescence-associated 
cell sorting (FACS), 4) laser capture microdissection for isolation of cells from solid tissues, 
5) microfluidics, such as that used in Drop-seq, Fluidigm and 10x Genomics workflows and 




Figure 4. General workflow for studying heart development at single-cell resolution. Created 
with BioRender.com. 
After lysis, the single cells are processed into cDNA libraries by reverse transcription of first-
strand cDNA using poly (dT) primers, which anneal to the poly(A) tails of eukaryotic 
mRNAs; second-strand synthesis using an engineered reverse transcriptase; and cDNA 
amplification by either PCR or in vitro transcription (Hwang et al. 2018). These steps are 
common for the commonly used protocols for single-cell library preparation (Ziegenhain et 
al. 2017). Choice of methods for cell isolation and cDNA library preparation depends on the 
desired cell number, cost, read depth, throughput, and acceptable level of bias (Hwang et al. 
2018, Shapiro et al. 2013). Currently, the Smart-seq3 workflow reconstructs the single-cell 
transcriptome in the highest detail by generating full-length high-depth libraries, i.e. generates 
more reads and detected genes per cell, and is therefore applicable for splice variant analysis 
(Picelli et al. 2014, Ziegenhain et al. 2017). On the other hand, the microfluidics-based 
platforms offer a higher throughput and cost-efficiency (Bageritz and Raddi 2019, Ziegenhain 
et al. 2017). 
The Illumina platform is based on sequencing by synthesis chemistry, and is widely used for 
the sequencing step. The choice of Illumina next-generation sequencing system is largely 
dependent on the scale of the single-cell study, which determines the reasonable depth of 
sequencing. The acceptable sequencing depth, depending on the experimental plan, can vary 
from 10,000 to several million reads per cell. In addition to the library preparation method, 
the sequencing depth can be further affected by choosing either paired-end or single-read 
sequencing, which determines whether the DNA is sequenced from one or both ends. 
Furthermore, during the library preparation, either single- or dual-indexes can be added to the 
cDNA library, which allows multiplexing, i.e. multiple libraries being pooled and sequenced 
together. (Single-Cell Sequencing Workflow: Critical Steps and Considerations, Illumina 
2020) 
6.4.2 Principles of basic single-cell analysis 
The technological breakthroughs leading to the generation of detailed large-scale single-cell 
data bring along new challenges for developing analytical tools to fully utilize it. The data 
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analysis can be carried out using in-house pipelines or by following available workflows, 
such as Seurat (Butler et al. 2018). 
After sequencing, data analysis starts with file conversion and demultiplexing (if 
multiplexing was applied), mapping reads to a reference genome, data quality control and 
filtering, normalization, and finally downstream analyses, such as data visualizations by 
clustering analysis (Gao 2018). The quality control and filtering out poor quality cells and 
doublets are commonly based on library size, number of genes per cell and proportion of 
mitochondrial genes; too large library indicating doublets and high mitochondrial gene 
expression commonly thought to denote apoptotic or pro-apoptotic cells (Ziegenhain et al. 
2017). Furthermore, the mRNA content per cell is usually normalized using either External 
RNA Control Consortium (ERCC) spike-ins or unique molecular identifiers (UMIs) method, 
mitigating the technical noise (Gao 2018). Other sources of technical variation include batch 
effect and dropout amplification bias, whereas cell cycle phase is an example of confounding 
biological variation (Hwang et al. 2018). What comes to cell cycle phase, it can contribute to 
meaningful and interesting biological variation, but can also mask other features of the 
dataset, such as continuous differentiation axes, as demonstrate in paper I. 
When the confounding noise has been addressed, exploration of the biological variation can 
start. Usually, one would start with principal component analysis for dimension reduction 
(Wold et al. 1987), which can also be used to explore sources of biological variance in the 
dataset. Identification of cell populations is one of the central goals of single-cell analysis, 
and is achieved by utilizing machine learning-based unsupervised clustering algorithms. 
Popular unsupervised clustering algorithms include k-means, hierarchical, density-based and 
graph-based clustering using the Louvain algorithm (Andrews and Hemberg 2018). These 
algorithms group single-cells in a multidimensional space based on their transcriptional 
signatures. Groups of cells and relationships between them are visualized by a dimensional 
reduction method, commonly using either t-distributed stochastic neighbor embedding (t-
SNE) or uniform manifold approximation and projection (UMAP). Compared to t-SNE and 
other dimensionality reduction techniques for single-cell analysis, UMAP has been shown to 
better conserve the global data structure, i.e. the relationship between clusters, and is 
particularly useful for the visualization of continuous cell transitions and branch points (Becht 
et al. 2018). The clustering can be further utilized for marker gene calling, which can be 
inputted into gene ontology (Ashburner et al. 2000) and pathway analysis for identification of 
cell types and biological processes. 
6.4.3 Developmental trajectories and co-regulated gene modules 
Reporter alleles have been long used to trace specific lineages and subpopulations based on 
marker gene expression in the heart and other organ systems. Single-cell RNA sequencing 
has enabled the development of computational analysis methods for identification of small 
subpopulations, lineages and population-specific gene regulatory networks. In the work 
included in my thesis, we explored and utilized some of the available algorithms to elucidate 
specific progenitor behaviors and dynamics along cardiac differentiation. 
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Although single-cell RNA sequencing only captures temporal snapshots of lineage 
development, several methods have been developed to trace the origin and future destiny of 
individual cells. RNA velocity is a method for the interference of differentiation direction of 
individual cells (Svensson and Pachter 2018; La Manno et al. 2018). RNA velocity is based 
on the distinction between spliced and unspliced RNA species, which can be derived from the 
single-cell RNA sequencing data. We applied RNA velocity analysis in our study presented 
in paper I, which revealed new insights regarding the developmental dynamics along the 
cardiac progenitor differentiation. 
Trajectory analysis is a one of the most popular approaches for single-cell analysis of lineage 
differentiation. Building a differentiation trajectory for lineage interference requires single-
cell analysis of multiple adjacent time points, the assumption being that the cells at slightly 
different developmental stages build a continuous spectrum. Multiple approaches have been 
developed for building developmental trajectories, including Monocle (Cao et al. 2019), 
Waterfall (Shin et al. 2015), SCUBA (Marco et al. 2014), DPT (Haghverdi et al. 2016), 
TSCAN (Ji and Ji 2016) and Slingshot (Street et al. 2018). The main goal of these methods is 
to reconstruct pseudotime by computationally ordering the individual cells along trajectories 
that can either be linear or branched. Pseudotime should on some level correlate with the data 
time points, but given that the cells captured at one time point are heterogeneous in their level 
of differentiation, pseudotime can better order the cells based on their transcriptional profiles. 
In addition to differentiating lineages, single-cell analysis provides information on genes that 
are co-expressed or co-regulated across groups of cells and pseudotime. Reconstruction of 
gene regulatory networks has been used for bulk RNA sequencing data, while single-cell 
RNA sequencing data can be analyzed using similar methods at higher cellular resolution. 
The basic assumption with gene module analysis is that groups of genes that are highly co-
expressed across single cells may also be co-regulated. (Chen et al. 2019) In the study 
presented in paper II, we utilized Louvain community analysis algorithm (Traag et al. 2019) 
in the Monocle3 pipeline to find modules of co-expressed genes among the genes that change 
as a function of Monocle-derived pseudotime (Cao et al. 2019; Qiu et al. 2017; Trapnell et al. 
2014). We identified modules of co-regulated genes that were specific for specific stages of 
cardiac differentiation while some modules were present across multiple stages. Other 
pipelines providing a framework for similar analysis include WGCNA (Langfelder and 
Horvath 2008; Li et al. 2018) and SCENIC (Aibar et al. 2017).  
Various pipelines have been developed for the different classes of single-cell analysis, many 
more than presented here. The pipelines are becoming increasingly user friendly, and several 
meta-analyses have compared their robustness, allowing more wet-lab researchers such as 
myself to utilize them efficiently. Many of the pipelines are complementary to each other, 
while others are better than others, and despite the positive impact of new pipelines, the 
choice of best single-cell workflow is not an obvious one. 
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6.5 IDENTIFICATION OF DAMAGING GENETIC VARIANTS 
A number of genetic approaches has been developed to identify genetic variation on 
individual and population level. These approaches include single nucleotide polymorphism 
(SNP) arrays, copy number variant platforms and Sanger sequencing, as well as next-
generation sequencing platforms whole-exome and whole-genome sequencing (Fahed et al. 
2013). These genetic tools have been combined with different study designs including: 1) 
family studies, in which inherited mutations are tracked by sequencing and phenotyping 
multiple family members, and 2) cohort studies, in which a large number of unrelated cases 
and healthy controls undergo phenotyping and sequencing for identification of rare genetic 
variants (Williams et al. 2019).  
Studies aiming to identify novel genetic variants associated with a patient phenotype utilize 
next-generation sequencing rather than the conventional sequencing platforms. In particular, 
a third type of study design, trio studies, in which the entire exomes or genomes of a proband 
and unaffected parents are sequenced, has enabled the detection of novel damaging de novo 
and recessive variants and variants with unclear Mendelian inheritance (Shabana et al. 2020). 
Due to the development of increasingly cost-effective methods for library preparation and 
sequencing, an increasing number of patients with various cardiac defects have been included 
in comprehensive genetic evaluation (Nees and Chung 2020). As a result, large sequencing 
studies have shed light on the prevalence and architecture of rare disease-causing mutations 
in CHD patients (Page et al. 2019, Jin et al. 2017, Sifrim et al. 2016, Preuss et al. 2016). 
In the sequencing study presented in paper II, we performed whole-genome sequencing of 
pediatric cardiac patients and their parents, and here I will give a brief overview on the 
technical workflow for variant calling. Similar to single-cell RNA sequencing, the next-
generation sequencing raw reads are first mapped to the reference human genome. Genome 
Analysis Toolkit (GATK) provides a comprehensive framework for variant analysis and was 
used by our collaborators to identify damaging genetic mutations in the patients (Van der 
Auwera et al. 2013; McKenna et al. 2010). In brief, analysis of the variants involved quality 
controls, as well as calls for single nucleotide variants, indels and copy number variants. 
After the genetic variants are identified, they are annotated according to their pathogenicity 
and frequency in the general population. How damaging the identified de novo and recessive 
mutations are, and whether they cause loss of function, is determined using in silico 
prediction algorithms, including MetaSVM and CADD. The variants are further prioritized 
according to predictions on their effect on protein function, and whether they are 
synonymous, non-synonymous, missense or nonsense, cause a frameshift, or cause a change 
within essential splice, start or stop site. After variant calling and prioritization, one can 
perform a burden analysis of damaging variants in the patient population as well as a 
functional enrichment analysis using similar methods as one would use in a single-cell 




6.6 STATISTICAL ENRICHMENT AND CROSS-REFERENCING 
After mapping the genetic landscape of a disease or phenotype, such as tetralogy of Fallot, in 
a large patient cohort, it can be interesting to understand which cell types these damaging 
variants affect. Both developmental and acquired diseases change the composition of cells 
and cell homeostasis in the affected tissue, and single-cell RNA sequencing data can provide 
information on even small changes in small and large cell populations and the gene 
regulatory networks within cells (Paik et al. 2020). Furthermore, information on the cellular 
composition of healthy tissues and their single-cell transcriptional profiles can aid in 
pinpointing cell types most affected in specific pathological conditions. 
To intersect single-cell transcriptomics with gene hits from whole genome sequencing, we 
used statistical tests based on Poisson and hypergeometric distribution in the study presented 
in paper II. In these analyses, we cross-referenced the de novo and recessive damaging 
genetic variants identified in Tetralogy of Fallot patients with 1) gene ontology terms, 2) 
marker genes for specific in vivo and in vitro cardiac populations identified through 
differential gene expression analysis, and 3) gene regulatory networks identified by module-
based co-regulation analysis in the human embryonic stem cell in vitro cardiac 
differentiation.  
Hypergeometric test is similar to the binomial test, and the popular enrichment analysis tools 
for gene ontology and pathway analysis, such as Metascape, Panther and String, are based on 
these statistical tests. Both binomial and hypergeometric tests can be used to calculate 
whether genes with damaging variants are over- or underrepresented in lists of genes derived 
from single-cell data, such as population markers. For example, Li and colleagues used 
hypergeometric test to study the enrichment of neuropsychiatric risk genes in modules of co-
expressed genes derived from single-cell sequencing of pre- and post-natal human brains (Li 
et al. 2018). To follow the benchmark set by Li and colleagues, we used the hypergeometric 
distribution method to calculate the enrichment of Tetralogy of Fallot candidate genes within 
modules of co-regulated genes. Lastly, to calculate the statistical enrichment of damaging de 
novo variants within population marker genes, we used Poisson distribution-based 
denovolyzeR statistical tool, which takes into account the expected number of de novo 
variants in a given population, mutability of the gene and the number of study subjects (Ware 
et al. 2015).  
6.7 ETHICAL CONSIDERATIONS 
Human embryonic stem cells: The generation of hESC lines involves destruction of human 
blastocysts, and thereby stem cell research can be seen as ethically controversial. The 
blastocyst, an early stage embryo, used for this purpose is usually obtained from an in vitro 
fertilization clinic, in which couples can give an informed consent to whether they allow the 
use of excess blastocysts not to be implanted to be used for scientific purposes (King and 
Perrin 2014).An alternative for embryonic stem cells is hiPSCs, derived by reprogramming 
somatic cells to become pluripotent. As the generation of iPSCs does not depend on human 
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embryos as a source, they are not seen controversial, as long as the donors have given their 
consent. The prominent ethical problem with hESC cell research is the moral status of the 
blastocyst that was destroyed in order to obtain the embryonic stem cells line. If the embryo 
should be treated as a human and given a moral status, generation of hESC lines is not 
justified, as we cannot obtain an informed consent from the embryo. One could argue, on the 
other hand, that these blastocysts, although potential human beings, would not be used for in 
vitro fertilization, and would anyway be disposed. The third viewpoint is a utilitarian one, 
namely that despite our view to the moral status of the embryo, the knowledge obtained from 
stem cell research justifies destroying human embryos. 
Collection and handling of patient information: Part of my PhD project is focused on 
studying mutations identified in a cohort of CHD patients. The first ethical issue regarding 
this study is that the patients are infants, and thereby not capable of giving an informed 
consent by themselves. Instead, the informed consent is obtained from the parents, who 
receive information concerning the study and its risks. The study itself does not cause harm 
for the patients, and only requires a blood sample for extraction of genetic material. However, 
the genetic information that can be extracted from the simple blood samples can reveal 
sensitive information about the study participants, such as predisposition to certain health 
problems. The second ethical issue concerns the handling of patient information. The most 
important concern for us is to keep the patient information confidential so that it will not 
become available for anyone else except the researchers working on the project. One way to 
ensure this was to encode the data for transport between different institutions involved in the 
study so that it is not easily accessible for someone outside academic research. Another way 
to protect sensitive patient information is to assign each patient an ID number, which will be 
used during the analysis to link together the patient phenotype and genotype instead of using 
the patients’ names or social security numbers. Lastly, the patients will be anonymous in the 
planned publication. 
Prenatal human cardiac samples: Our studies have involved obtaining human embryonic 
tissues for single-cell analysis as well as immunofluorescence and confocal microscopy-
based analyses of markers for cardiac populations. The human embryonic tissues were 
obtained from a clinic at Karolinska Hospital following a valid ethical permit. When possible, 
we also used single-cell analyses done by other laboratories in order to avoid redundancy and 
use the available single-cell data to its full potential. 
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7 RESULTS 
7.1 PAPER I 
With this study, we aimed to deeply characterize the developmental path of cardiac 
progenitors through single-cell transcriptional analysis of hESC cardiac differentiation. 
Generation of high-quality Smart-seq2 single-cell cDNA libraries from cells collected at 
closely adjacent differentiation time points allowed us to build a connected roadmap of the 
cardiac differentiation process. 
A widely adopted WNT-modulation based protocol (Lian et al. 2013) was used to achieve 
cardiac differentiation of hESCs. In order to capture a broad spectrum of cellular states, cells 
were collected on days 3-9 and 15, each time point in two separate differentiation batches. 
These timepoints cover the differentiation process from undifferentiated cells expressing 
pluripotency-associated genes to beating cardiomyocytes expressing canonical 
cardiomyocyte marker genes. In order to avoid collection bias, cells were picked manually 
using a hand-pulled capillary needle. In total, 1024 single-cell cDNA libraries were prepared 
for sequencing following the Smart-seq2 protocol. After sequencing and quality control, 925 
cells passed the quality metrics and were included in downstream analyses. Despite the 
relatively small number of sequenced cells, visualization of connected lineage trajectories 
was possible due to the good sequencing depth and the collection of cells at close timepoints. 
Seurat version 3 pipeline was utilized for basic analyses, including principal component 
analysis, dimensional reduction, unsupervised clustering and marker gene analysis. In 
addition to a differentiation axis of pluripotent stem cells to cardiac progenitors and 
cardiomyocytes, we observed smaller diverging populations of cells, which were identified as 
endoderm and cardiac fibroblast-like cells.  
In the past years the hESC-derived cardiac cells have been mapped to their human in vivo 
counterparts mostly based on electrophysiological properties and expression of specific 
genes. A previous study indicated that the hPSC-derived cardiac cells are comparable to 
human fetal cells at global transcriptional level (Van den Berg et al. 2015). In order to study 
the single-cell transcriptional resemblance between the hESC-derived populations and cells in 
a human embryonic heart in more depth, we integrated the in vitro data with a previously 
reported single-cell analysis of a human embryonic heart at 5 WPC (Cui et al. 2019). The 
cells from the in vitro differentiation time points day 3-7 were developmentally too early to 
transcriptionally overlap with the human embryonic in vivo cells, and were therefore 
excluded from the analysis. The cells from the later time points showed co-clustering with the 
human fetal heart. Marker gene and gene ontology analyses were used to identify the shared 
populations, including ventricular cardiomyocytes, atrial cardiomyocytes, fibroblast-like cells 
likely of epicardial origin, proliferative cardiac myogenic cells, endothelial cells and cardiac 
progenitors. These results verify the identities of hESC-derived populations, and validate the 
relevance of the hESC-based differentiation system to study early cardiovascular cells which 
are difficult to access in vivo.  
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We found that the day-8 and -9 hESC-derived cardiac progenitors clustered together with 5-
week embryonic atrial cardiomyocytes, whereas the day-15 hESC-derived cardiomyocytes 
resembled the embryonic ventricular cardiomyocytes. A previous study comparing hPSC-
derived with human fetal cardiac cells found that the in vitro differentiation protocol 
generates cells with both atrial and ventricular phenotypes (Van den Berg et al. 2015). Our 
results indicate, that these phenotypic differences are at least partially related to the maturity 
of the cardiomyocytes in the hESC differentiation system. We identified transforming growth 
factor β-induced protein (TGFBI) as a marker for the cardiac fibroblast-like cells both in the 
human embryonic heart and the hESC-cardiac differentiation, and validated its expression by 
immunocytochemistry both in vitro and in vivo. TGFBI is important in the modulation of the 
extracellular matrix (Hashimoto et al. 2013), and is likely involved in the migration of the 
fibroblasts in the developing heart. A cardiac fibroblast-like population has been previously 
identified in the hPSC-cardiac differentiation (Zhang et al. 2019; Friedman et al. 2018). Our 
results further indicate, that this population closely resembles epicardium-derived fibroblasts. 
Using the UMAP “differentiation roadmap”, we identified the branching points of cardiac 
differentiation where the non-myogenic cell types diverge from the cardiomyocyte lineage. 
Based on this analysis, the cardiac fibroblast-like cells do not originate from the same early 
cardiac progenitor population as the cardiomyocytes. In line with in vivo embryonic 
development (Wei and Wang 2018), the endoderm population diverges from the cardiac 
differentiation at a branch point population, which expressed mesendoderm markers, such as 
T, EOMES and MIXL1. Regarding the cardiomyocyte differentiation axis, we identified a 
branch point between the early progenitors and the committed NKX2-5-expressing cardiac 
progenitors, which also gives rise to a small population of endothelial cells. We found, that 
this branch point was characterized by the expression of specific extracellular matrix-related 
genes, COL3A1 in particular, suggesting that extracellular matrix plays an important role in 
cardiac development. This finding is in line with the human developmental in vivo data, 
which has shown that the expression of extracellular matrix proteins, such as COL3A1, 
follow dynamic changes along the cardiomyocyte differentiation (Cui et al. 2019). To further 
define the branching point, we regressed out the majority of the cell-cycle variance from the 
data, which further refined the connections between populations, and studied the specific 
signaling pathways regulating the lineage transition using pathway analysis. Specifically, we 
found that WNT and integrin signaling-related genes were expressed by the branch point 
population, which further supports the importance of extracellular matrix-related genes in 
cardiac differentiation. 
Although the dimensional reduction is an excellent tool for studying the global data structure 
and the transcriptional differences, similarities and connections between populations, it does 
not fully utilize the transcriptional information hidden in the single-cell RNA sequencing 
data. Therefore, we employed RNA velocity analysis, which uses the information on spliced 
and unspliced mRNAs, to derive the developmental direction of each cell (La Manno et al. 
2018; Svensson and Pachter 2018). Interestingly, RNA velocity vectors indicated that 
progenitors maintain their undifferentiated state until the abovementioned branching point, 
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after which the cardiac lineage shows differentiation direction towards cardiomyocytes, 
indicating commitment to a cardiac fate. Maintenance of stemness is an important property of 
cardiac progenitors, allowing them to proliferate and maintain a pool of migratory cells in the 
developing heart before cardiac commitment and differentiation into cardiomyocytes of the 
cardiac chambers and the outflow tract (Zhou et al. 2011). 
To explore the role of ISL1 transcription factor in this differentiation process, we conducted 
additional single-cell analysis of ISL1 knockout hESC-derived differentiating cells at day 6 of 
the cardiac differentiation protocol. We found, that loss of ISL1 expression did not 
significantly affect the transcriptional signature of the day-6 progenitors. However, similar to 
a recent study on ISL1 knockout hPSC cardiac differentiation (Quaranta et al. 2018), we saw 
a delay in the cardiac commitment of the progenitors, as the NKX2-5-expressing population 
was missing in the knockout differentiation at this timepoint. Similar to wild-type, the ISL1 
knockout hESC generated a small endoderm population. In addition to that, the ISL1 
knockout cells generated an ectopic neuroectoderm population. ISL1 is known to be involved 
in the differentiation of non-cardiomyocyte lineages, such as neuronal cells (Zhao et al. 2020; 
Teratani-Ota et al. 2016) and the endoderm-derived pancreatic b-cells (Gupta et al. 2018; 
Pezzolla et al. 2015). Further research is needed to study the specific role of ISL1 in the fate 
decision between cardiac and neural progenitor differentiation, and to identify where the 
neural-like population diverges from the cardiac and other differentiation axes. To gain 
further insight, single-cell RNA sequencing of ISL1 knockout differentiation at several 
timepoints of the early differentiation should be conducted. 
In summary, paper I provides novel insights in the differentiation of early cardiac progenitors 
at single-cell resolution. In particular, by generating a connected roadmap of hESC-based 
cardiac differentiation, we were able to study the emergence and segregation of cardiac 
progenitors and lineages from pluripotent cells, and add new detail on the molecular 
mechanisms regulating these events.  
7.2 PAPER II 
Previously published large whole-exome sequencing studies have mapped the genetics 
underlying the pathogenesis of Tetralogy of Fallot in patient cohorts of European descent 
(Page et al. 2019; Jin et al. 2017). However, little is known about other cohorts. In this study, 
whole-genome sequencing was performed on 150 Chinese Tetralogy of Fallot cases and their 
healthy parents following informed consent and ethical approval. In order to exclude 
syndromic cases, patients were screened for DiGeorge syndrome-associated deletion in the 
genomic locus 22q11.2. Among the 150 trios, two were found to be biologically unrelated 
and two of the probands had trisomy 21, a chromosomal aneuploidy commonly associated 
with Tetralogy of Fallot. These four trios were excluded from the study. This study is focused 
on covering the genetic findings in the coding genome, whereas the non-coding genetic 
variants will be reported in a subsequent study. 
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Thanks to the sequencing of both proband and two unaffected parents, damaging de novo 
mutations could be identified. In total 140 protein-altering de novo mutations, including 
single nucleotide variants and indels and excluding synonymous mutations, were identified in 
92 cases. 28 of these findings were loss-of-function mutations. According to a global burden 
test, the Tetralogy of Fallot cases harbored more damaging de novo mutations, particularly 
loss-of-function mutations, than the general population in average. In addition, a significant 
enrichment of damaging de novo variants was found among human genes that are intolerant 
to loss-of-function mutations, as well as known CHD susceptibility genes. These results 
indicate, that de novo mutations significantly contribute to the disease risk in the cohort. 
In addition to single nucleotide variants and short indels, whole-genome sequencing reliably 
detects copy number variants. Copy number variants are usually associated with genetic 
syndromes, but rare de novo copy number variants can also cause non-syndromic forms of 
CHD and Tetralogy of Fallot (Soemedi et al. 2012; Greenway et al. 2009). In total 12 small 
and 4 large de novo copy number variants were identified in 14 patients. Out of these 16 copy 
number variants, 8 disrupted exonic regions and the remaining 8 were found outside the 
coding genome. Whereas the copy number variants of the coding region disrupted some of 
the known cardiac genes, further analysis is needed to fully understand the role of the 
noncoding ones in the pathogenesis of Tetralogy of Fallot. In particular, whether the 
noncoding copy number variants disrupt cardiac-specific regulatory regions. 
In addition to damaging de novo mutations, rare damaging recessive, both homozygous and 
compound heterozygous, variants have been previously shown to be enriched in CHD cases 
(Jin et al. 2017). In the Chinese cohort, 28 cases harbored 32 rare damaging recessive (10 
homozygous and 12 compound heterozygous) genotypes, when using relatively strict criteria. 
If the criteria are relaxed, 236 recessive variants could be found. 
In order to gain an overview of the biological function of the genes with damaging mutations 
in the Tetralogy of Fallot cohort, gene ontology enrichment analysis was performed including 
all damaging de novo and recessive variants. 167 significant gene ontology terms were 
identified, which grouped into 21 enriched clusters. The terms associated with the top 
significantly enriched clusters were related to cardiac function and development, as well as 
sensory organ development. The functional enrichment among the Chinese Tetralogy of 
Fallot cases was compared with a cohort of Tetralogy of Fallot patients with European 
ancestry reported by the PCGC (Jin et al. 2017). Interestingly, we found differential 
functional enrichment in de novo variants between these two populations, which is likely 
related to the differences in the genetic background between the two cohorts. 
In order to identify human developmental cardiac cell populations with enrichment of 
disease-associated gene expression in spatial and temporal manner, the gene set of damaging 
de novo variants was cross-referenced with single-cell RNA sequencing data. For this 
analysis, we used data from three previous studies reporting single-cell RNA sequencing and 
spatial transcriptomics of human 6.5-7 week embryonic heart (Asp et al. 2019), single-cell 
analysis of human 4.5-10 week embryonic heart (Sahara et al. 2019), and single-cell analysis 
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of in vitro hESC cardiac differentiation (paper I). We found enrichment of the de novo variant 
genes among marker genes for the myogenic populations across all single-cell datasets, 
notably those of the cono-ventricular progenitors. The cono-ventricular progenitors will be 
described in more detail in paper III. Based on the spatial transcriptomics data, significant 
enrichment was found among the genes specifically expressed in the outflow tract region. We 
performed the same enrichment analysis on the de novo variants identified in Tetralogy of 
Fallot cases of the PCGC patient cohort, but no enrichment was found. 
To pinpoint timepoints along cardiac differentiation affected by the identified mutations, we 
intersected both de novo and rare recessive findings with pseudotime (single-cell) analysis of 
the hESC cardiac differentiation. Specifically, we cross-referenced the lists of Tetralogy of 
Fallot-associated genes with gene co-expression modules identified using the Monocle 
pseudotime trajectory analysis pipeline. Many of these gene co-expression modules showed 
timepoint-specific patterns, i.e. some of the modules were expressed early in cardiac 
differentiation (by the pluripotent/pre-cardiac cells), some at the intermediate progenitor 
stages, and some towards the end of the differentiation (by committed cardiac 
progenitors/cardiomyocytes). Hence, by cross-referencing the disease-associated genes with 
the co-expression modules, we could identify groups of Tetralogy of Fallot-associated genes 
that are co-expressed as well as find their developmental expression patterns along the 
cardiac differentiation. We also identified the gene co-expression modules related to VEGF 
and NOTCH signaling pathways. Through these analyses, we identified a small number of 
gene co-expression modules which were enriched for the Tetralogy of Fallot-associated 
genes. Two of these modules were expressed early in the differentiation and two were 
expressed at the late timepoints. Yet, another module, which showed enrichment of Tetralogy 
of Fallot-associated genes, was specific for VEGF and NOTCH signaling pathways. 
Interestingly, we found that several of the known Tetralogy of Fallot-associated genes (TBX1, 
GATA4, TBX5, NKX2-5, FLT4 and NOTCH1) belonged to the same co-expression modules 
that showed enrichment of disease-associated genes identified in the Chinese patient cohort.  
Our study maps the genetic landscape of a non-syndromic Tetralogy of Fallot cohort, 
identifying causative de novo and rare recessive variants in the patient population. By 
functional annotation and comparison with variants identified in a similar cohort of European 
descent, specific pathways and cellular mechanisms, as well as differences between ethnic 
groups were identified. Comparisons with single-cell transcriptomics revealed associations of 
known and novel Tetralogy of Fallot genes with cono-ventricular progenitors and specific 
gene expression patterns along cardiac differentiation. This analysis resulted in the 
identification of a large set of genes with currently no known function in heart development. 
These genes are both strongly associated with complex CHD and expressed at specific 




7.3 PAPER III 
In this study, single-cell transcriptional analysis was applied to study the cell type 
heterogeneity in human embryonic and fetal hearts as well as hESC cardiac differentiation, 
which resulted in the identification of a novel subset of progenitors marked by the WNT 
signal activator LGR5, a leucine-rich repeat-containing G-protein-coupled receptor. The 
LGR5+ population emerges in the cono-ventricular/proximal outflow tract region around 4-5 
WPC in a human embryo, and a similar progenitor population was also found in the hESC-
cardiac differentiation at the early progenitor stage. LGR5 has been previously shown to 
mark several types of adult stem cells, including those of hair follicles, small intestine and 
colon, in which it has been shown to regulate proliferation (Barker and Clevers 2010). The 
study presented here investigates the role of LGR5 in early heart development. 
Cell populations arising in the hESC cardiac differentiation were characterized and isolated 
by FACS and population identities were validated by qPCR analysis. The populations 
included ISL1+PDGFRA+ multipotent cardiac progenitors on day 3 as well as ISL1+ 
intermediates and ISL1- differentiated cells expressing lineage markers TNNT2 
(cardiomyocytes), HCN4 (pacemaker cells), PECAM1 (endothelial cells), and SMMHC 
(smooth muscle cells) on days 6 and 10, respectively. The isolated cell types and 
undifferentiated hESCs were prepared into bulk RNA sequencing libraries and sequenced to 
study the global transcriptional expression on a population level. Notably, LGR5 was 
identified as a novel marker for the multipotent cardiac progenitors on day 3, and was 
selected for further investigation. 
FACS analysis verified that the developmental stage of the PDGFRA+ cardiogenic 
mesoderm marked by LGR5 occurs after MESP1+ mesoderm but precedes the peak of ISL1 
expression on day 6. In addition, LGR5 expression was detected in the non-mesodermal 
lineages on day 3, although these cells did not show ISL1 expression. To test the potency of 
the LGR5+ mesodermal progenitors, a clonal assay was performed on cells collected on day 
3. PDGFRA and LGR5 double positive cells as well as single positive and double negative 
populations were included in the experiment. Single-cell-derived clones were grown and their 
differentiation potential was tested under three differentiation conditions, namely those 
promoting cardiomyocyte, smooth muscle cell and endothelial cell differentiation. Both 
PDGFRA+LGR5+ and PDGFRA+LGR5- showed the capacity to generate all three cardiac 
lineages, although PDGFRA+LGR5+ cells favored the cardiomyocyte lineage more 
frequently than PDGFRA+LGR5- cells. These results suggest that while the LGR5+ cells 
represent a multipotent progenitor, they predominantly differentiate into cardiomyocytes. 
To further investigate the LGR5+ cardiac progenitor population, single-cell transcriptional 
analysis was performed on cells collected on days 3, 6 and 15 of the cardiac differentiation 
protocol. These cells generated clusters representing stages of differentiation ranging from 
undifferentiated cells expressing OCT4 to cardiomyocytes expressing TNNT2. Cells 
expressing LGR5 were found in two intermediate clusters, and the expression profiles of 
LGR5+ and LGR5- cells in these clusters were explored. Interestingly, cells expressing LGR5 
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showed higher expression of the mesodermal cardiogenic markers MESP1, PDGFRA, TBX6, 
BMP2 and BMP4 as well as SHF-related marker genes ISL1 and BMP4 compared to the cells 
not expressing LGR5. The single-cell analysis of hESC cardiac differentiation suggest that 
LGR5 expression may be related to the SHF progenitor development. 
To relate the in vitro-derived cardiac populations to their in vivo counterparts, cells isolated 
from altogether seven human embryonic and fetal hearts ranging from 4.5 to 10 WPC were 
subjected to single-cell sequencing. This analysis revealed small populations of endothelial 
cells, smooth muscle cells and fibroblasts, which were removed from further analyses due to 
low abundance. Subsequent analyses on the pooled data revealed ten clusters named cono-
ventricular progenitors, free-wall ventricular progenitors, intermediates of outflow tract, 
intermediates of ventricle, early atria/pace maker cells, late atria, cardiomyocytes expressing 
extracellular matrix genes, late cardiac mesenchymal cells, cono-ventricular muscle cell and 
free-wall ventricular muscle cells. 
Analysis of differentially expressed genes between embryonic heart-derived single-cell 
clusters revealed a substantial difference between the cono-ventricular and free-wall 
ventricular progenitors. While the former population showed specific expression of Wnt 
signaling-related genes (e.g. LGR5, RSPO3 and LEF1), Wnt signaling was rather inhibited in 
the free-wall ventricular population. Overall, gene ontology analysis of the genes specifically 
expressed by the cono-ventricular population showed enrichment of terms related to 
extracellular matrix, heart development, and Wnt and TGF-b pathways. Genes expressed by 
the free-wall ventricular progenitors also showed enrichment for extracellular matrix and 
TGF-b pathway, and additionally showed enrichment for genes related to cell adhesion, 
positive regulation of cell proliferation and PI3K-Akt pathway.  
The localization of the LGR5+ISL1+ cells in the proximal outflow tract was validated by 
immunostaining in 4.5 WPC human embryonic heart sections. A subpopulation of these cells 
expressed TNNT2, indicating cardiac specification, as well as Ki67, indicating proliferation 
of the LGR5+ myogenic population. LGR5 expression was low or undetectable in the later 
human developmental time points studied. To study whether the LGR5+ population is 
evolutionarily conserved between human and mouse, immunostaining of Lgr5 in mouse heart 
sections at E9.5-10.5 and lineage tracing using Lgr5-EGFP-IRES-CreERT2 knockin mice 
together with Rosa26-floxed stop cassette tdTomato reporter mice were carried out. Neither 
of the approaches resulted in a signal in the proximal outflow tract, indicating absence of the 
Lgr5+ cardiac progenitor population in the mouse at all stages of cardiogenesis. These results 
strongly suggest that the LGR5+ population of the outflow tract is human specific. 
To further study the functional role of LGR5 during human cardiogensis, the CRISPR/Cas9 
system was used to generate an LGR5 knockout hESC line. After validation, the LGR5 
knockout cells were subjected to cardiac differentiation. As indicated by qPCR analysis, the 
LGR5 knockout did not affect the expression of the mesoderm marker MESP1 on day 3, 
whereas the expression of ISL1, LEF1 and TNNT2 was significantly decreased compared to 
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the wild type on later time points. Analysis on the day 6 population indicated, that the LGR5 
knockout cells generated less ISL1+TNNT2+ cardiomyocyte intermediates whereas other 
intermediates (pacemaker, smooth muscle cell and endothelial cell) were not affected. On day 
14, the number of TNNT2+ cardiomyocytes was lower in LGR5 knockout hESC 
differentiation compared to wild type, while the numbers of smooth muscle and endothelial 
cells slightly increased. Furthermore, flow cytometry analysis showed, that the LGR5 
knockout hESCs generated approximately one third of the number of cardiomyocytes 
compared to wild type differentiation. The results were validated by subjecting the LGR5 
knockout and wild type hESCs to an alternative growth factor-based differentiation protocol, 
which indicated that LGR5 knockout negatively affects cardiomyocyte differentiation, 
independent of which protocol is used. Moreover, qPCR analysis on day 14 showed that the 
LGR5 knockout cardiomyocytes expressed less cono-ventricular myocyte-specific genes, 
whereas they expressed specific free-wall ventricular genes on the same level as wild type 
cardiomyocytes. These results indicate, that LGR5 plays a specific role in the differentiation 
of the cono-ventricular cardiomyocytes. 
Lastly, cardiogenesis-specific transcriptional regulation of LGR5 expression was studied. In 
silico analysis revealed a putative novel human-specific MESP1 binding site upstream of the 
transcription start site of the LGR5 promoter, as well as a LEF1 binding site upstream of the 
transcription start site of the ISL1 promoter. The in silico findings were validated through 
chromatin immunoprecipitation assays using chromatin derived from cells collected on days 
0 and 3 of cardiac differentiation, which indicate recruitment of MESP1 on LGR5 promoter 
and LEF1 on ISL1 promoter. The assay was repeated using the LGR5 knockout hESCs, 
which showed decreased LEF1 binding to the ISL1 promoter, suggesting that LGR5 plays a 
role in LEF1-mediated activation of ISL1 expression. Taken together, these results suggest 
that LGR5-signaling and transcriptional regulation mediated by ISL1 are interconnected and 
play a key role in the differentiation and development of the progenitors of cono-ventricular 
myocytes. 
Comparison between the in vitro (bulk RNA-seq) and in vivo (single-cell) populations 
indicated similarity in the transcriptional profiles between the in vitro-derived multipotent 
cardiac progenitors/cardiac intermediates and in vivo cono-ventricular progenitors. Likewise, 
the transcriptional profiles of in vitro cardiomyocytes resembled those of the in vivo free-
ventricular myocytes. To pinpoint in vivo cardiac populations (cono-ventricular vs free-wall 
ventricular) that may be differentially affected in CHD, a binomial test was carried out. Based 
on their expression of CHD-associated genes (identified by the PCGC), cono-ventricular 
progenitors and cono-ventricular myocytes appear to be a hotspot in the pathogenesis of 
CHD. 
To conclude, LGR5 is a novel marker and regulator of the ISL1+ cardiac cono-ventricular 
myocyte lineage. Given the central role of myogenic progenitors of the outflow tract in the 
pathogenesis of conotruncal cardiac defects, this population may hold an important key to 
understanding and modeling CHD. 
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8 GENERAL DISCUSSION AND OUTLOOK 
The studies constituting this doctoral thesis provide new insights into the development of 
cardiac progenitors and shed light on their role in the pathogenesis of complex CHD. 
Specifically, we advanced the understanding of cardiac progenitors by: 
1. Building a differentiation roadmap of hESCs to cardiomyocytes, which revealed the 
developmental relationships and dynamics of the cardiomyocyte lineage and other 
cell types.  
2. Defining the embryonic cardiac cell types, developmental timepoints and cardiac 
progenitor-related gene ensembles contributing to the development of non-syndromic 
Tetralogy of Fallot. 
3. Identifying and characterizing a novel cardiac progenitor population, which might 
play a central role in the development and abnormalities of the human cardiac outflow 
tract. 
A main premise of this thesis is that the hESC cardiac differentiation closely recapitulates the 
genetic programs of human embryonic cardiogenesis. In recent years, there has been a 
growing interest in studying early heart development, as well as the adult heart, at single-cell 
resolution (Paik et al. 2020). The heart progenitors, which are the focus of this thesis, are of 
particular interest due to their applicability in understanding human heart development, 
disease modeling and cell replacement therapy (Protze et al. 2019). Recent single-cell 
analyses of cardiac differentiation intermediates from hPSCs (Friedman et al. 2018; Churko 
et al. 2018; Ruan et al. 2019) and pre-natal human hearts (Asp et al. 2019; Cui et al. 2019; 
Suryawanshi et al. 2020), have revealed novel insights into the early cardiac progenitor 
populations as well as embryonic and fetal cardiac cell types. To advance the field, we used 
high temporal resolution to build a connected roadmap of the hESC cardiac differentiation 
(paper I) and characterized the cono-ventricular and free-wall ventricular populations in the 
human embryonic heart in great detail (paper III). Taken together, these studies provide both 
an extensive resource of transcriptional signatures and a detailed characterization of the gene 
expression dynamics of human cardiac lineage specification.  
In paper I, we conducted a single-cell analysis of multiple differentiation timepoints, which 
allowed us to build a connected roadmap of the hESC cardiogenesis. It is evident from our 
results and other recent single-cell studies, that we should think of cardiac progenitors passing 
through momentary transitional stages rather than having a fixed transcriptional signature 
(Tyser et al. 2021). Therefore, pinpointing and defining a cardiac progenitor with a specific 
transcriptional signature, which can for example be robustly generated for cell replacement 
therapies, is a challenge. Although the field of cardiovascular regeneration has not yet 
reached a consensus about the optimal hPSC-derived cell type for cardiac cell replacement 
therapy (Chien et al. 2019), the essential first step is to fully understand the differentiation 
process. Together with previous studies, our study provides a guide for outlining specific 
progenitor stages, and visualizes the branching points and onset of specification along the 
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differentiation trajectory of the cardiac lineage. In particular, the RNA velocity and trajectory 
analysis in our study provides further information on the maintenance of an early progenitor-
like identity (stemness) versus cardiac commitment, which could prove valuable as current 
research efforts are attempting to prolong the progenitor-like proliferative state to increase the 
graft size upon injection of hPSC-derived cardiac progenitors into infarcted hearts (Schwach 
et al. 2020). 
Moreover, the study presented in paper I adds new insights into the hESC-derived non-
myogenic populations generated alongside cardiomyocytes. Fibroblasts in particular are an 
integral component of the myocardium (Moore-Morris et al. 2015), and our study defines 
their identity in the hESC cardiac differentiation system. In terms of future applications, the 
ability to generate cardiac fibroblast-like cells in vitro facilitates research on cardiac 
development and disease, as well as provides cells for cardiac tissue engineering (Zhang et al. 
2019). Additionally, our study suggests, that ISL1 transcription factor may play a role in the 
decision between cardiac and neural lineages. In order to gain a full picture of the segregation 
of the neural-like population in the ISL1 knockout differentiation, single-cell RNA 
sequencing of cells collected on days 3, 4, and 5 of the ISL1 knockout differentiation could be 
conducted. Both a previous study and our results indicate that ISL1 expression is not 
necessary for cardiomyocyte differentiation (Quaranta et al. 2018). Our study therefore rather 
suggests that it contributes to the differentiation process as a partial molecular switch between 
lineages. 
The second main premise of this thesis is that single-cell analysis of human cardiac 
progenitor lineages provides a framework for investigating the pathogenesis of CHD. 
Complex forms of CHD are rarely curable, and although a large body of research has 
addressed the pathogenesis of CHD, it remains largely elusive (Nees and Chung 2020). 
Understanding the pathophysiology through genetics and cell and molecular biology, along 
with thorough clinical characterization, is the first step towards improved personalized 
interventions. Next-generation sequencing has opened new possibilities for mapping the 
mutational landscapes of various types of structural CHD (Shabana et al. 2020). Our 
knowledge on the Mendelian, de novo and rare recessive variants causing CHD and 
Tetralogy of Fallot specifically is rapidly growing due to the recent and ongoing research 
efforts (paper II, Jin et al. 2017; Page et al. 2019; Richter et al. 2020). The diversity of genetic 
mutations found suggests that the genetic landscape of CHD is highly complex and context-
dependent, and there is still much to be discovered. In particular, the role of mutations within 
the non-coding genome in CHD pathogenesis is elusive (Richter et al. 2020), and we plan to 
explore these in a future study based on the whole-genome sequencing analysis of the 
Tetralogy of Fallot cohort. 
Cardiac outflow tract development is the focal point underlying the pathogenesis of many 
types of complex CHD (Neeb et al. 2103; Nakajima 2010). Both defective alignment and 
incomplete septation can lead to abnormal outflow tract development, and previous studies 
have associated these disease processes with the SHF and neural crest progenitors (Neeb et al. 
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2013). To shed light on the connection between conotruncal disease phenotypes (Tetralogy of 
Fallot in particular) and early cardiac populations, we intersected CHD genetics with single-
cell analyses of human heart development in vivo and in vitro, as presented in papers II and 
III. Specifically, we found that the myogenic cells building the cardiac chambers, and notably 
the outflow tract, are mainly affected by the Tetralogy of Fallot-associated genetic mutations. 
No enrichment of Tetralogy of Fallot-associated genes was found among the non-myogenic 
cell types, such as neural crest cells, highlighting the importance of the myogenic cardiac 
progenitors and cardiomyocytes in the pathogenesis of non-syndromic cases of Tetralogy of 
Fallot.  
The LGR5+ cono-ventricular progenitors emerged from these analyses as a novel subset of 
ISL1+ SHF derivatives, which likely play a central role in the outflow tract morphogenesis 
and pathogenesis of conotruncal cardiac malformations. The cono-ventricular progenitors 
contribute to the outflow tract myocardium and are distinct from the progenitors that form the 
right ventricle (Nakajima 2010), i.e. the free-wall ventricular cardiomyocytes, as discussed in 
paper III. In addition to specifically marking the cono-ventricular progenitor population, 
LGR5 plays a role in their lineage progression, as deletion of LGR5 resulted in blocking the 
molecular machinery promoting cardiac differentiation. 
It would be interesting to study whether the LGR5+ cono-ventricular progenitor population is 
affected in the embryonic/fetal hearts with Tetralogy of Fallot phenotype. This is likely the 
case since they express several genes indicated in CHD and Tetralogy of Fallot specifically, 
as shown in papers II and III. Future studies are needed to understand the differential roles of 
LGR5+ and LGR5- progenitor-derived cardiac lineages in the heart development, in 
particular in the development of cono-ventricular versus free-wall ventricular 
cardiomyocytes. However, the LGR5+ cardiac population is not present in the developing 
mouse heart, and hence cannot be studied in mouse models by lineage tracing. Instead, 
hESC-cardiac differentiation and non-human primate cardiogenesis could be used as model 
systems to further study the involvement of LGR5+ progenitors in the CHD pathogenesis. 
Establishing the onset and timeline of CHD in the early heart development, especially in 
human, is one of the fundamental steps towards understanding the CHD pathogenesis. In 
paper II, we used the hESC differentiation roadmap presented in paper I to pinpoint 
developmental (temporal) timepoints along the pluripotency-to-cardiomyocyte transition 
affected by Tetralogy of Fallot-associated genetic mutations. Our approach was adapted from 
a previous study, which investigated the timing of neurological disease-associated genes 
based on single-cell RNA sequencing analysis of the developing human brain (Li et al. 2018). 
We found that subsets of the disease-associated genes were expressed at specific stages of the 
cardiomyocyte differentiation, both at the pluripotent/pre-cardiac stage and at the late cardiac 
progenitor/cardiomyocyte stage. A previous study, which intersected CHD-associated genes 
with a time-course bulk transcriptional analysis of cardiac development in mouse, arrived to 
similar conclusions (Li et al. 2014). While these findings indicate that the genetics and 
pathogenesis of Tetralogy of Fallot affect multiple stages of cardiac development, we were 
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able to identify specific subsets of disease-associated genes specifically expressed by the 
cardiac progenitors. The role of many of these genes in cardiac development is currently 
unknown, and therefore they are interesting candidates for hPSC- and animal model-based 
loss- and gain-of-function studies. 
Finally, to put our findings in a wider context, we compared the genetic landscape of Chinese 
Tetralogy of Fallot cases with a previously reported cohort of European descent (Jin et al. 
2017). Although we observed an overlap in the genetic findings from these two cohorts, we 
also observed discrepancies, in particular related to the molecular and cellular functions of the 
genes indicated in the two patient populations. Previous studies have indicated that ethnicity 
contributes to the differences between patient phenotypes and genetics in complex CHD (Van 
Der Linde et al. 2011; Freeman et al. 2008). In particular, the occurrence of left versus right 
sided heart phenotypes differs between patients with complex CHD of Asian and European 
descent (Zimmerman et al. 2017; Rokicki et al. 2003). Our findings support these notions 
regarding the genetic landscapes of Tetralogy of Fallot. 
In the research presented in this thesis, we have applied in vitro cardiogenesis using hESCs as 
a platform for understanding early lineage segregation and developmental progenitor 
dynamics. Furthermore, we have built comprehensive transcriptional datasets of the early 
human in vitro and in vivo cardiac populations. Together with genetic analysis of complex 
CHD, this data highlights the role of cardiac progenitors in the pathogenesis of CHD. The 
currently ongoing research efforts to further characterize the early human and non-human 
primate heart development will continue to advance our understanding of cardiogenesis, and 
might eventually solve the riddle around CHD. 
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